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 Breast cancer, surpassing lung cancer with the highest estimated new cases, is 
closely associated with obesity. Cancer research continues to divulge the complexity of the 
disease including the recognition that stromal cells must cooperate with the cancerous 
epithelium for cancer growth and metastasis. 
 Parabens are a class of esters of 4-hydroxybenzoic acid that is ubiquitous in the 
environment, and act as anti-microbial agents that sustain the shelf-life of personal care 
products, pharmaceuticals, food, etc. Parabens are classified as endocrine disrupting 
chemicals, are estrogenic, and bioaccumulate within adipose tissue.   
 Activation of fibroblasts is caused by tissue damage leading to the release of 
inflammatory cytokines to stimulate wound healing. Low dose (0.02, 0.1, and 1 μM) 
methyl-, propyl, and butylparaben (MP, PP, and BP) treatment onto murine 3T3-L1 and 
human primary breast (BRF) fibroblasts led to an inflammatory response by the 
upregulation of inflammatory cytokines including interleukin-1β (IL-1β) and 
cyclooxygenase-2 (COX2) via activation of the NF-κB pathway (Chapter III). MP, PP, and 
BP also upregulated matrix metalloproteinase-9 (MMP9), indicating potential influence in 
metastasis. Paraben-treated fibroblasts also increased the mRNA expression of CYP19A1 
otherwise known as aromatase, which influences the conversion of androgen to estradiol.  
Secretions from paraben-treated fibroblasts also obtained the ability to enhance 
proliferation of estrogen receptor positive (ER+) breast cancer cells (MCF7).  
 To evaluate the contribution of adipocytes, 3T3-L1 and BRF adipocytes were 
treated with MP, PP, and BP and induced upregulation IL-1β, COX2, MMP9, and 
CYP19A1 (Chapter IV). The secretions from paraben-treated adipocytes also enhanced the 
proliferation of MCF7 cells.  
 In conclusion, we have shown that environmental achievable low doses of parabens 
enhance the inflammatory response of stromal fibroblasts and adipocytes, and the 
secretions produced from paraben exposure enhance the proliferation of breast cancer cells. 
Our results support the existing evidence that paraben exposure may lead to increased risks 
of breast cancer and suggest the stromal link between parabens and breast cancer. Further 
v 
studies are warranted to confirm the effects of parabens on breast stromal cells and 
carcinogenesis in vivo and to establish the role of NF-B pathway.  
  
vi 
TABLE OF CONTENTS 
 
Chapter 1 : Introduction .................................................................................................... 1 
1.1. References ............................................................................................................... 5 
1.2. Appendix ................................................................................................................. 8 
Chapter 2 : Literature Review ......................................................................................... 10 
2.1.  Introduction ........................................................................................................... 11 
2.2. Parabens, Endocrine Disruptors, and Breast Cancer ............................................ 12 
2.2.1. Human Paraben Exposure ......................................................................... 12 
2.2.2. Parabens are EDCs .................................................................................... 13 
2.2.3. Parabens and Breast Cancer ...................................................................... 14 
2.3. Estrogenic Effects of Parabens ............................................................................. 15 
2.3.1. Estrogenicity ............................................................................................. 15 
2.3.2. Mammary Tissue Development ................................................................ 16 
2.3.3. Menstrual Cycles ...................................................................................... 17 
2.4. Mechanisms of Action by Parabens ...................................................................... 18 
2.4.1. Estrogen Receptor ..................................................................................... 18 
2.4.2. Progesterone Receptor .............................................................................. 19 
2.4.3. Human Epidermal Growth Factor Receptor ............................................. 20 
2.4.4. Androgen and Glucocorticoid Receptor ................................................... 20 
2.4.5. G-Protein Coupled Receptor ..................................................................... 21 
2.5. Parabens Effect on Breast Cancer Progression ..................................................... 21 
2.5.1. Mimic Estrogen in Inducing ER+ Breast Cancer Gene Expression ......... 22 
2.5.2. Induce Genome Instability ........................................................................ 23 
2.5.3. Evoke Breast Cancer Proliferation............................................................ 26 
2.6. Parabens Effect on Breast Cancer Metastasis ....................................................... 28 
2.6.1. Cell-Surface Transformation .................................................................... 28 
2.6.2. Stem Cell Markers .................................................................................... 29 
2.6.3. Cellular Migration and Invasion ............................................................... 29 
2.7. Conclusion ............................................................................................................ 30 
2.8. References ............................................................................................................. 31 
Chapter 3 : Parabens Induce Inflammation in Stromal Fibroblasts Leading to Breast 
Cancer Cell Proliferation .................................................................................................. 36 
3.1. Abstract ................................................................................................................. 37 
3.2. Introduction ........................................................................................................... 38 
3.3. Materials and Methods .......................................................................................... 41 
3.4. Results ................................................................................................................... 44 
3.4.1. Parabens Induce mRNA Expression of Inflammatory Genes and 
CYP19A1 in Murine and Human BRF Fibroblasts .................................................. 44 
3.4.2. Parabens Activate NF-κB Signaling in Murine and Human Fibroblasts .. 47 
3.4.3. Conditioned Media from Parabens-Treated Fibroblasts Regulates Breast 
Cancer Cell Proliferation .......................................................................................... 48 
3.5. Discussion and Conclusion ................................................................................... 49 
3.6. References ............................................................................................................. 55 
vii 
3.7. Appendix ............................................................................................................... 60 
Chapter 4 : Parabens Induce Inflammation in Stromal Adipocytes Leading to Breast 
Cancer Cell Proliferation .................................................................................................. 68 
4.1. Abstract ................................................................................................................. 69 
4.2. Introduction ........................................................................................................... 70 
4.3. Materials and Methods .......................................................................................... 72 
4.4. Results ................................................................................................................... 77 
4.4.1. Parabens Induce mRNA Expression of inflammatory genes and CYP19a1 
in Murine 3T3-L1 Adipocytes and Human BRF Adipocytes ................................... 77 
4.4.2. Parabens Regulate NF-κB Signaling in Murine and Human Derived 
Adipocytes ................................................................................................................ 79 
4.4.3. Conditioned Media from Parabens-Treated Adipocytes Regulates Breast 
Cancer Cell Proliferation .......................................................................................... 80 
4.5. Discussion and Conclusion ................................................................................... 81 
4.6. References .............................................................................................................. 85 
4.7. Appendix ................................................................................................................ 89 
Chapter 5 : Conclusions and Future Directions............................................................... 95 
5.1. Conclusions ............................................................................................................ 96 
5.2. Significance of the Study ....................................................................................... 97 
5.3. Limitations and Future Directions ......................................................................... 98 




LIST OF TABLES 
 
Table 3.1. Primer sequences for qRT-PCR using SYBR green ........................................ 67 
ix 
LIST OF FIGURES 
 
Chapter 1 
Figure 1.1. Characterization of breast cancer. .................................................................... 8 
Figure 1.2: Diagram of breast tumor microenvironment. ................................................... 9 
Chapter 3 
Figure 3.1. Paraben chemical structures. .......................................................................... 60 
Figure 3.2. Parabens induce inflammatory gene expression in 3T3-L1 fibroblasts. ........ 61 
Figure 3.3. Parabens induce inflammatory gene expression in human BRF fibroblasts. . 62 
Figure 3.4. Parabens activate NFκB reporter in both murine and human fibroblasts. ...... 63 
Figure 3.5. Paraben activates NFκB signaling in murine fibroblasts. .............................. 64 
Figure 3.6. Paraben activates NFκB signaling in human BRF fibroblasts. ...................... 65 
Figure 3.7. The conditioned media from paraben-treated fibroblasts promotes breast 
cancer cell proliferation. ........................................................................................... 66 
Chapter 4 
Figure 4.1. Adipocyte differentiation of 3T3-L1 and the human BRF cells..................... 89 
Figure 4.2. Parabens induce mRNA expression of inflammatory genes and Cyp19a1 in 
3T3-L1 adipocytes. ................................................................................................... 90 
Figure 4.3. Parabens induce mRNA expression of inflammatory genes and CYP19A1 in 
human BRF adipocytes. ............................................................................................ 91 
Figure 4.4. Parabens activate NFκB reporter in murine adipocytes. ................................ 92 
Figure 4.5. Paraben activates NFκB signaling in murine adipocytes. .............................. 93 
Figure 4.6. The conditioned media from paraben-treated adipocytes promotes breast 




LIST OF ABBREVIATIONS 
 
AARSL   Alanyl-tRNA Synthestase Like 
AIAN    American Indian/Alaska Native 
Akt    Protein Kinase B 
ALDH1   Aldehyde Dehydrogenase 1 
AM-1    Adipocyte Maintenance Media 
ANOVA   Analysis of Variance 
API    Asian/Pacific Islander 
BCL2    B-Cell Lymphoma 2 
BenzP    Benzylparaben 
β-gal    β-Galactosidase 
BMI    Body Mass Index 
BP    Butylparaben 
BRCA1   Breast Cancer Type 1 
BRCA2   Breast Cancer Type 2 
CaBP-9k   Calbindin-D9k 
CAPE    Caffeic Acid Phenethyl Ester 
cAMP    Cyclic Adenosine Monophosphate 
CARΔ1   Coxsackievirus and Adenovirus Receptor Delta 1 
CBMN   Cytokinesis-Block Micronucleus 
CCD    Charge-Coupled Device 
CD-1    Cluster of Differentiation 1 
CDK    Cyclin Dependent Kinase 
CELF5   CUGBP Elav-Like Family Member 5 
ChIP    Chromosome Immunoprecipitation 
CLS    Crown-Like Structures 
CM    Conditioned Media 
COX2    Cyclooxygenase-2 
CS-FBS   Charcoal-Stripped Fetal Bovine Serum 
xi 
CYP19A1   Cytochrome P450 Family 19 Subfamily A Member 1 
DCIS    Ductal Carcinoma In Situ 
DEX    Dexamethasone 
DM2    Differentiation Media 2 
DMEM   Dulbecco’s Modified Eagle’s Medium 
DMSO    Dimethyl Sulfoxide 
DSB    Double Stranded Break 
E2    Estradiol 
E2F1    E2F Transcription Factor 1 
ECM    Extracellular Matrix 
EDC    Endocrine Disrupting Chemicals 
EEF    Estradiol Equivalence Factor 
EMT    Epithelial to Mesenchymal Transitions 
EP    Ethylparaben 
ER    Estrogen Receptor 
ERK1/2   Extracellularly Regulated Kinase 1/2 
ESR1    Estrogen Receptor 1 
ESR2    Estrogen Receptor 2 
ETP    Estrogen-Equivalent Total Paraben 
FBS    Fetal Bovine Serum 
FSH    Follicle-Stimulating Hormone 
GI    Gastrointestinal 
GPER1   G Protein-Coupled Estrogen Receptor 1 
GPR30   G Protein-Coupled Receptor 30 
GR    Glucocorticoid Receptor 
HER2    Human Epidermal Growth Factor Receptor 2 
HR    Hormone receptor 
HRG    Heregulin 
HSD    Hydroxysteroid Dehydrogenase 
IBP    Isobutylparaben 
xii 
Icabp    Intestinal Calcium Binding Protein 
ICI182,780   Faslodex 
IκBα    Nuclear Factor of Kappa Light Polypeptide Gene Enhancer 
    in B-Cells Inhibitor, Alpha 
IKKβ    Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta 
IL1β    Interleukin 1 Beta 
IL17RB   Interleukin 17 Receptor B 
Ins    Insulin 
IPP    Isopropylparaben 
Irf7    Interferon Regulatory Factor 7 
Itmap    Integral Membrane-Associated Protein 1 
IVIS    In vivo Imaging System 
LBD    Ligand Binding Domain 
LH    Luteinizing Hormone 
LOEL    Lowest-Observed-Effect Levels 
LPS    Lipopolysaccharide 
Luc    Luciferase 
MAPK    Mitogen-Activated Protein Kinase 
MCF7    Michigan Cancer Foundation-7 
MCF10A   Michigan Cancer Foundation-10A 
MLL2    Myeloid/Lymphoid Mixed Lineage Leukemia 2 
MIX    Methylisobutylxanthine 
MMP    Matrix Metalloproteinases 
MMTV   Mouse Mammary Tumor Virus 
MP    Methylparaben 
NFκB    Nuclear Factor Kappa-Light-Chain-Enhancer of Activated  
    B Cells 
NHB    Non-Hispanic Black 
NHW    Non-Hispanic White 
NOAEL   No Observed Adverse Effect Level 
xiii 
NOEL    No-Observed-Effect Levels 
Oct4    Octamer-Binding Transcription Factor 4 
ORO    Oil Red O 
OTOF    Otoferlin 
PDX    Patient Derived Xenograph 
PGE2    Prostaglandin E2 
PI3K    Phosphoinositide 3-Kinase 
PKC    Protein Kinase C 
PM-1    Preadipocyte Media-1 
PP    Propylparaben 
PR    Progesterone Receptor 
PRF    Phenol Red Free 
PRLR    Prolactin Receptor 
RT-PCR   Reverse Transcription-Polymerase Chain Reaction 
SD    Sprague Dawley 
SE    Standard Error 
TCS    Triclosan 








Breast cancer is a complex disease with a variety of different classifications, including 
location of abnormal cells, level of invasiveness, hormone receptor expression, and age of 
onset (Figure 1.1.) (Harbeck, Penault-Llorca et al. 2019). The breast is composed of a 
network of alveoli, comprised of milk-secreting epithelial cells, which are connected to 
form a breast lobule (Macias and Hinck 2012). A multitude of lobules is connected to 
lactiferous ducts, all of which form the mammary gland (Macias and Hinck 2012). 
Abnormal cells can be found in either the milk duct epithelium, ductal carcinoma, or lobule 
epithelium, lobular carcinoma (Hong, McMasters et al. 2018). As the abnormal cells 
remain within the epithelium, cancer is classified as in situ; however, as they spread into 
neighboring regions, cancer is classified as invasive (Hong, McMasters et al. 2018). 
Hormone receptor (HR) expression, particularly estrogen (ER) and progesterone (PR), as 
well as human epidermal growth factor receptor 2 (HER2) expression,  are typical markers 
to classify breast cancers and provide avenues for treatment (Harbeck, Penault-Llorca et 
al. 2019). HER2 is a protein that functions as a growth factor activating signaling pathways 
such as mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K/Akt), 
phospholipase C, protein kinase C (PKC), and signal transducer and activator of 
transcription all leading to cellular proliferation (Harbeck, Penault-Llorca et al. 2019). 
Breast cancers are often categorized based on patient’s age as either pre-menopausal or 
post-menopausal. Before menopause women produce estrogens primarily from the ovaries. 
However, ovarian estrogen cessation occurs after menopause causing other tissues to 
become the major estrogen producers (Amadou, Ferrari et al. 2013, Neuhouser, Aragaki et 
al. 2015). 
 
Approximately 48,100 cases of non-invasive ductal carcinoma in situ (DCIS) and 268,600 
cases of invasive cancer are estimated in 2019 (DeSantis, Ma et al. 2019). The majority of 
new diagnoses occur in post-menopausal women with HR+/HER2- expression (DeSantis, 
Ma et al. 2019). Treatments have proven to be effective over time as death rates have been 
decreasing since 1995 (DeSantis, Ma et al. 2019). However, incidence rates remain 
constant over the last 15 years (DeSantis, Ma et al. 2019). In attempts to prevent breast 
cancer occurrence, many factors outside of genetics have been identified to be associated 
3 
with breast cancer including obesity, exposure to xenoestrogens, etc. (Bandera, Maskarinec 
et al. 2015, Neuhouser, Aragaki et al. 2015). Obesity in postmenopausal women has a direct 
association with the risk of breast cancer (Chan, Vieira et al. 2014, Arnold, Jiang et al. 
2016). However, controversially higher adiposity in premenopausal women appears to be 
protective against breast cancer and associated with lower risk of premenopausal breast 
cancer (Nichols, Schoemaker et al. 2017).  
 
A breast cancer tumor is comprised of more than abnormal epithelial cells, but a 
conglomerate of other cell types surround these epithelial cells and have been found to 
communicate via paracrine factors (Radisky and Radisky 2007, Bussard, Mutkus et al. 
2016, Semenza 2016). This surrounding microenvironment, or stroma, of cells consists of 
fibroblasts, adipocytes, immune cells, macrophage, endothelial cells, mast cells, etc. 
(Figure 1.2.) (Soysal, Tzankov et al. 2015). Stromal inflammation has been identified in 
breast cancer patients’ biopsies, which are linked with worse prognosis (Radisky and 
Radisky 2007, Majidinia and Yousefi 2017). Obesity leads to chronic inflammation, which 
in turn can influence local stromal inflammation permitting breast proliferation and 
progression (Brown 2014, Allen and Jones 2015, Agresti, Meneghini et al. 2016). Breast 
cancer occurs in stages with the worst stage being metastasis, and stromal inflammation is 
closely linked with breast cancer progression to metastasis (Soysal, Tzankov et al. 2015, 
Suhail, Cain et al. 2019).  
 
Environmental chemicals, such as parabens, found in personal care products, food and 
household items that have been observed to accumulate in breast cancer tissue and adipose 
tissue (Barr, Metaxas et al. 2012, Harvey and Everett 2012, Wang, Asimakopoulos et al. 
2015). The identification of parabens within breast tissue of cancer patients leads to an 
increasing intrigue in the characterization of parabens' actions in breast cancer 
development. Parabens have been shown to be estrogenic in nature and to directly promote 
epithelial cell growth (Charles and Darbre 2013, Darbre and Harvey 2014). However, it is 
unclear whether parabens can induce changes in the stromal fibroblasts and adipocytes to 
produce an inflamed stroma. 
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It is well recognized that aggressive cancerous epithelial cells must acquire the “hallmarks” 
of cancer, which include evading suppressors, resisting cell death, replicating, eliciting 
vascularization, initiating tissue invasion, acquiring unlimited energy, evading immune 
targeting, and sending proliferation signals to survive (Hanahan 2011, Darbre and Harvey 
2014). The stroma must provide the necessary support to the cancerous cells to meet these 
hallmarks. As parabens are detected in breast cancer tissue, it is conceivable that these 
chemicals could contribute to this carcinogenic stroma. Our previous studies have 
demonstrated parabens’ ability to create an obesogenic stroma by forcing fibroblasts to 
differentiate into adipocytes (Hu, Chen et al. 2013). Previous results also suggest that 
parabens may negatively change stromal cells, creating a carcinogenic stroma that has pro-
inflammatory, pro-angiogenic and pro-mitogenic characteristics.  
 
In this dissertation, the stromal fibroblasts and adipocytes were subjected to three different 
types of most common parabens, methyl- (MP), propyl- (PP), and butylparaben (BP) to 
characterize their inflammatory effects. We hypothesize that at environmentally achievable 
doses parabens can influence stromal (1) fibroblasts (Chapter 3) and (2) adipocytes 
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Figure 1.1. Characterization of breast cancer.  
Physiology of human breast demonstrating the essential anatomy to understanding breast 
cancer types. Identifying four common ways of classifying breast cancer based on location, 
invasiveness, receptor expression, and age of onset. Adapted from: Harbeck N, Penault-




Figure 1.2: Diagram of breast tumor microenvironment. 
Demonstration of the cellular connectivity and interactions between cells within the tumor 
stroma.  
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CHAPTER 2 : 
LITERATURE REVIEW  
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2.1.  Introduction 
Breast cancer remains the second leading cause of cancer-related deaths in women in the 
United States behind lung and bronchial cancers in 2018 (DeSantis, Ma et al. 2019). This 
trend has occurred since the 1960s when uterine and colon cancer deaths in women began 
to decline (DeSantis, Ma et al. 2019). However, awareness, screening, and treatment 
advancements have aided in lowering the death rates of breast cancer by 39% from 1989 
to 2015 (DeSantis, Ma et al. 2019). Invasive breast cancer incidence rates have remained 
stable from 2005 to 2014 (DeSantis, Ma et al. 2019). 
 
The occurrence of breast cancer is a result of the compounding effects of risk factors to 
which women are exposed. The risk factors for breast cancer can be grouped into non-
modifiable factors (family history and hereditary gene) and modifiable (environmental) 
factors (Darbre 2006). The familial risk factors include a family history of breast cancer, 
other breast diseases, or high breast density. The hereditary risk factor is the individual that 
has inherited a BRCA1, BRCA2, or other breast cancer-related gene mutations. Non-
modifiable risk factors only account for approximately 5-10% of breast cancers, whereas 
90% of breast cancer occurrence is thought to be related to modifiable, environmental 
factors (Darbre 2006). There are many environmental risk factors, such as obesity, 
sedentary lifestyle, oral contraceptives, xenoestrogens, etc., and exposures that are 
modifiable and are associated with increased breast cancer risk. Additionally, nulliparity, 
having first child after the age of 30, and postmenopausal hormone use are also considered 
breast cancer risks (ACS 2018).  
 
It is increasingly recognized that exposure to environmental chemicals is associated with 
increased risks of developing breast cancer. Many of such environmental chemicals, such 
as bisphenol A, atrazine, benzophenone-1 and nonylphenol, are reported to be estrogenic 
and are thought to be implicated in breast carcinogenesis (Burks, Pashos et al. 2017). 
Parabens are a class of these environmental chemicals, and recent evidence has suggested 
that parabens are estrogenic and are implicated to impact a variety of physiological 
abnormalities from reproduction to cancer (Smith, Souter et al. 2013, Darbre and Harvey 
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2014, Guerra, Sanabria et al. 2017). Recently, significant progress has been made on the 
relationship between parabens and breast cancer. In this review, a new understanding of 
parabens’estrogenic effects, mechanisms of action, and their effects on breast cancer 
development and progression are summarized.  
 
2.2. Parabens, Endocrine Disruptors, and Breast Cancer 
2.2.1. Human Paraben Exposure 
Parabens, 4-hydroxybenzoic acid alkyl esters, are absorbed or ingested daily from personal 
care products (such as cosmetics, lotions, deodorants, hair care products, and shaving 
products), pharmaceuticals and foods (Darbre and Harvey 2014). Parabens enter into the 
body through dermal or gastrointestinal absorption and are distributed systemically 
demonstrated by isolation of intact paraben in tissue, blood, breast milk, placenta, and urine 
(Sandanger, Huber et al. 2011, Kolatorova 2017, Shen, Liang et al. 2017).  
 
The four most common parabens present in biological fluids are methylparaben (MP), 
ethylparaben (EP), propylparaben (PP) and butylparaben (BP), in order of increasing side 
chain length (Sandanger, Huber et al. 2011, Darbre and Harvey 2014, Zhou, Chen et al. 
2018). Parabens can either get metabolized by esterases in the gastrointestinal tract, liver, 
or dermis for excretion or can travel through circulation to tissues for metabolism or 
bioaccumulation (Wang, Asimakopoulos et al. 2015, Kolatorova 2017). MP is the most 
abundant in systemic fluids as the metabolic rate of esterases increases with the size of the 
paraben’s side chain. Additionally, these chemicals have a weak affinity for human serum 
albumin allowing for greater accessibility to peripheral tissues (Greige-Gerges, Kaissi et 
al. 2013).  
 
As parabens are ubiquitously utilized in industry as an anti-microbial reagent to preserve 
products and increase shelf-life, there is an increasing amount of evidence indicating 
human exposure to parabens are ubiquitous as well. The estimated total intake of parabens 
from food has been estimated to range from 307 – 940 ng/kg body weight, and absorption 
differs depending on age with infants having the highest total absorption due to application 
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of personal care products (Darbre and Harvey 2014). However, the estimated total intake 
of parabens via personal care product usage ranges from 31 – 766 µg/kg body weight (bw) 
again with infants being at the upper limit (Darbre and Harvey 2014). Women have higher 
urine concentrations of parabens as compared to men (Zhou, Chen et al. 2018). The total 
concentrations of parabens in men’s urine ranges from 0.5-79.1 ng/mL, whereas women 
range from 17-237 ng/mL (Zhou, Chen et al. 2018). As personal care product usage leads 
to a greater systemic level of parabens, previous research has identified the effect of skin 
cream usage and systemic paraben levels.  The positive correlation between the percentage 
of skin area creamed per day and median plasma level of MP demonstrates the direct 
connection between personal care products with paraben absorption and systemic 
distribution (Sandanger, Huber et al. 2011). This association between cosmetic 
applications and paraben burden can be confirmed by the disappearance of 
isopropylparaben and isobutylparaben in all urine samples after a ban was imposed in 2014 
on the utilization of these two chemicals in cosmetics (Zhou, Chen et al. 2018). 
 
2.2.2. Parabens are EDCs 
Parabens are endocrine disrupting chemicals (EDCs), which have the ability to alter the 
normal endocrine function and cause adverse effects in development, reproduction, 
neurology, and immunity (NIEHS 2018). The most common examples of EDCs are 
parabens, dioxins, polychlorinated biphenyls, bisphenol A, etc. found in products like 
pesticides, plastics, detergents, food, toys, cosmetics, and pharmaceuticals (NIEHS 2018). 
Many EDCs have been identified as possessing estrogenic properties that increase the basal 
estradiol levels, which in post-menopausal women can lead to exacerbated breast epithelial 
cell proliferation and tumor growth (Darbre 2006, Yager 2006, Rodgers, Udesky et al. 
2017).  
 
Epidemiological evidence directly linking EDC exposure with breast cancer is limited due 
to the vast amount of exposure variability. As EDCs are commonly used as preservatives 
in consumables and hygiene productions, absorption occurs through ingestion, dermal 
contact, and inhalation (Kolatorova 2017). Therefore, increased personal care product 
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usage leads to greater exposure to EDCs, and women have higher levels of EDCs in bodily 
fluids as compared to men due to the increased usage of cosmetics and lotions (Zhou, Chen 
et al. 2018). Previously, individual EDCs are often identified as having a weak estrogenic 
effect making their association with breast cancer negligible (Pastor-Barriuso, Fernandez 
et al. 2016). However, prolonged daily exposure, bioaccumulation, and interactions of 
xenoestrogens can invoke local and systemic endocrine changes (Pastor-Barriuso, 
Fernandez et al. 2016). 
 
It has been demonstrated that urban communities have a three- to four-fold increased risk 
of estrogen receptor (ER) positive breast cancer compared to rural communities (Dey, 
Soliman et al. 2010, Dey, Soliman et al. 2010). In Egypt, more urban areas had a higher 
incidence of total and ER+ breast cancer from 2001-2006 and uterine cancer from 1999-
2002 with little differences in nutritional status, length of breastfeeding, childbearing age, 
etc. (Dey, Hablas et al. 2010, Dey, Soliman et al. 2010). Female cancers without hormonal 
etiology, such as leukemia, are less stratified between urban and rural communities, 
suggesting a hormonal contribution in the urban lifestyle (Dey, Hablas et al. 2010). It is 
possible that the greater use of plastics, insecticides, detergents, personal care products, 
and cosmetics in urban as compared to rural communities increases the EDC absorption 
leading to a greater xenoestrogen burden. 
 
2.2.3. Parabens and Breast Cancer 
As parabens have been identified to increase breast cancer growth in vitro, extractions of 
breast tissue from serial locations from the axilla to sternum were analyzed for paraben 
presence (Barr, Metaxas et al. 2012, Darbre and Harvey 2014). The tissue levels of MP is 
16.6 ng/g of tissue, which is greater than previously documented (Darbre, Aljarrah et al. 
2004, Barr, Metaxas et al. 2012). Additionally, the concentration of PP in breast tissues is 
found to be 16.8 ng/g of tissue, higher than MP. BP, EP, and isobutylparaben (IBP) are all 
present at lower levels (5.5, 3.4, and 2.1 ng/g of tissue respectively) with a total paraben 
concentration of 85.5 ng/g of tissue (Darbre and Harvey 2014). However, there is no 
significant association between serial paraben localization and known patient tumor 
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location (Barr, Metaxas et al. 2012). Parabens have greater bioaccumulation within the 
outer region (axilla and lateral) of the breast than inner regions (mid and medial) (Barr, 
Metaxas et al. 2012). The mammary glands are centrally located in the inner regions, while 
the outer regions consist more of adipose tissue. The lack of association between paraben 
levels and percent of breast density confirms the lower presence of parabens within the 
inner regions (Sprague, Trentham-Dietz et al. 2013). Parabens localized in the outer region 
of the breast is speculated to be caused by the use of deodorants (Barr, Metaxas et al. 2012). 
However, an alternative hypothesis could be that the parabens are accumulating in the 
adipose tissue of the breast as parabens are suggested to be the most abundant 
environmental phenol present in adipose (Wang, Asimakopoulos et al. 2015).  
 
2.3. Estrogenic Effects of Parabens 
2.3.1. Estrogenicity 
Parabens have been identified to bind ER receptors and affect ER-related gene expression. 
The estrogenic response is also attenuated with the pre-treatment of an ER inhibitor (ICI 
182,780). In addition, parabens increase uterine weight, which is a classic physical 
outcome that indicates estrogenic activity. The influence of parabens on ER increases with 
the length of the alkyl chain and with the branching of the side chain. Moreover, MP, EP, 
PP, BP, and BenzP have been calculated to have an estradiol equivalence factor (EEF) of 
1.25(10-7), 6.48(10-7), 2.39 (10-6), 8.09(10-6), and 1.3(10-5) respectively, confirming the 
increase in estrogenicity with increasing alkyl side chain length (Lange, Kuch et al. 2014). 
MP and EP produce binding energies of -49.35 and -53.38 kcal/mol when automated 
docking into human ERα ligand-binding domain (LBD) is conducted (Sun, Yu et al. 2016). 
This release of energy indicates binding confirming the formation of hydrogen bonds in 
the LBD at Glu353/Arg394 with the hydroxyl group of the parabens (Sun, Yu et al. 2016).  
 
In addition to cell models demonstrating estrogenic effects, the standard for measuring 
estrogenic activity in the animal model is determined by evaluating the uterine weight 
changes upon paraben exposure. Parabens' estrogenicity has been demonstrated in CD-1 
mice (Lemini 1997). Recently, the lowest-observed-effect levels (LOEL) for MP and EP 
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to increase relative uterine weight in Sprague-Dawley (SD) rats was reported to be 20 
mg/kg bw/day and 4 mg/kg bw/day (Sun, Yu et al. 2016). The no-observed-effect levels 
(NOEL) are similar to previous publications at 4 mg/kg bw/day for MP and 0.8 mg/kg 
bw/day for EP, which is similar to the upper limit of human paraben absorption  (Lemini 
1997, Sun, Yu et al. 2016). In addition to increases in uterine weight, paraben induced 
significantly higher levels of estrogen responsive biomarkers compared to control animals 
including intestinal calcium-binding protein (icabp), integral membrane-associated protein 
1 (itmap1), calbindin-D 9k (CaBP-9k), and progesterone receptor (PR) in the rat uterine 
tissue (Sun, Yu et al. 2016).  
 
2.3.2. Mammary Tissue Development 
The mammary gland is an intricate network of ducts that are surrounded by a stroma that 
changes throughout different stages of life (Macias and Hinck 2012). The mammary gland 
consists of epithelial ducts expanding from the nipple into a fat pad formed by adipocytes, 
endothelial cells, fibroblasts, etc. with a function to secrete milk for newborn survival 
(Macias and Hinck 2012). During the pubertal phase, mammary glands begin to develop 
with scattered ducts lined with two layers of epithelial cells termed mammary tree (Macias 
and Hinck 2012, Howard and Lu 2014). The breast epithelium is comprised of luminal 
cells that line the ducts and of myoepithelial cells (Arendt and Kuperwasser 2015). In 
humans, the ends of the ducts terminate in a fibroblastic stroma (Howard and Lu 2014). 
Mammary tissue development in women begins during puberty and continually has 
morphology changes as a woman enters pregnancy, lactation, and post-lactation (Howard 
and Lu 2014, Arendt and Kuperwasser 2015). When a woman enters puberty the 
myoepithelial cells within ducts proliferate in response to estrogen and progesterone 
(Russo 1999, Arendt and Kuperwasser 2015). Estrogen induces the growth of mammary 
ducts in cooperation with growth factors by activating the estrogen receptors located in 
both the epithelium and stromal cells (Silberstein 1982). Pregnancy leads to morphological 
changes within breasts including epithelial growth to form milk-secreting alveoli and 
adipose tissue recession (Macias and Hinck 2012). Once lactation is complete, a process 
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of involution begins when epithelial cells sense stagnant milk and begin to revert back to 
the pre-pregnancy structure (Macias and Hinck 2012). 
 
Methylparaben exposure at a low dose that was previously determined to produce urinary 
metabolite concentrations comparable to those found in US population, in the perinatal and 
prepubertal time periods caused less development of adipose tissue but increased ductal 
tree expansion within the fat pad and growth of the glandular tissue, respectively, in SD 
female rats (Gopalakrishnan, Teitelbaum et al. 2017). Female SD rats were treated with 
MP or triclosan (TCS) at 0.105 and 0.05 (mg/kg/day), representing 1/10,000 and 1/1,000 
no observed adverse effect levels (NOAEL) of these chemicals respectively. These low 
doses were previously determined to produce urinary metabolite concentrations 
comparable to those reported for the US population (Gopalakrishnan, Teitelbaum et al. 
2017). Pubertal MP exposure induced more glandular tissue with a high degree of 
branching in the SD female rats, which was associated with differential expression of 295 
genes (Gopalakrishnan, Teitelbaum et al. 2017).  Moreover, it was found that pubertal MP 
exposure up-regulated or down-regulated subsets of genes that were also up-regulated or 
down-regulated in breast cancers compared to nearby normal tissues (Gopalakrishnan, 
Teitelbaum et al. 2017). Paraben exposure, therefore, at a prepubescent age can affect 
breast tissue development by stimulating epithelial cell growth.  
 
2.3.3. Menstrual Cycles 
The menstrual cycles of women are managed by the alterations in hormones that occur in 
a cyclical pattern. There are both steroidal and non-steroidal hormones secreted that 
contribute to these changes, and the two most abundant and well-identified steroidal 
hormones include estradiol and progesterone (Messinis, Messini et al. 2014). Estradiol, 
secreted from the follicle, plays a primary role in the follicular phase of the menstrual cycle 
(Messinis, Messini et al. 2014). In the follicular phase, which involves the oogenesis and 
maturation, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) increase 
stimulating the release of estradiol (Messinis, Messini et al. 2014). During the peak of these 
hormone levels, the oocyte is released from the follicle and ovulation occurs. The surge of 
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LH and FSH elicit higher levels of estradiol and progesterone in the luteal phase. Estrogen 
and progesterone induce negative feedback on the hypothalamic-pituitary-gonadal axis in 
which it decreases the production of LH and FSH (Messinis, Messini et al. 2014). 
Therefore, by the end of the luteal phase, LH and FSH are returning to normal levels along 
with estrogen and progesterone signaling the beginning of a new cycle and menses.  
 
Parabens can also influence the menstrual cycles in women due to estrogenic properties 
determined by comparing bleeding records with urinary concentrations of parabens. In 127 
premenopausal women of normal body mass index (BMI), the urinary concentrations of 
parabens were similar to that of US females at 137, 1.3, 29.1, and 0.50 ng/mL for MP, EP, 
PP, and BP. When estrogen-equivalent total paraben (ETP) of the four parabens was 
calculated, high urinary ETP and BP concentrations were associated with a shorter 
menstrual cycle (Nishihama, Yoshinaga et al. 2016). It is suggested that the greater levels 
of basal estrogen from the simulation by parabens could initiate the negative feedback loop 
more frequently, thereby inhibiting the amount of LH and FSH production and 
consequently, the LH surge and ovulation.  
 
2.4. Mechanisms of Action by Parabens 
2.4.1. Estrogen Receptor 
As discussed in the previous section, parabens have the ability to bind ER and activate ER 
signaling (Lange, Kuch et al. 2014, Sun, Yu et al. 2016). Additionally, they increase the 
gene and protein expression of ER (ESR1 and ESR2, their alternative names ERα and ERβ) 
(Wrobel and Gregoraszczuk 2014). ESR1 functions in cellular proliferation of mammary 
gland cells, while ESR2 functions by antagonizing ESR1. ESR1 over-expression is linked 
to breast cancer, while ESR2 expression is lost in breast cancer patients. MP, PP, and BP 
at 20 nM significantly enhanced ESR1 and ESR2 mRNA expression upon 24 h of treatment 
in MCF7 cells. MP and PP also increased ESR1 mRNA expression in normal breast 
epithelial cells (MCF10A) at 6 h (Wrobel and Gregoraszczuk 2014).  
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ERα protein (ESR1 product) expression was greatly enhanced by MP, PP, and BP at 48 h 
than by estradiol, the positive control, in MCF7 cells, which function as a model for a ER+ 
breast cancer tumor. (Wrobel and Gregoraszczuk 2014). MP induced the longest response 
in MCF7 cells with increasing protein expression at 72 h, similar to estradiol stimulation, 
which could be due to relatively low MP metabolism rates (Wrobel and Gregoraszczuk 
2014). As for comparisons, MP increases the ERα protein expression in normal breast 
epithelial cell line, MCF10A cells at 48 h, whereas both MP and PP had effects at 72 h 
(Wrobel and Gregoraszczuk 2014). Moreover, the dependence of ER for the paraben's 
effects was demonstrated by the co-treatment with ER inhibitor ICI 182,780 on MCF10A, 
which attenuated the parabens effect. (Wrobel and Gregoraszczuk 2014).  
 
All three parabens increased ERβ protein in MCF7 cells at 48 h and only MP at 72 h 
(Wrobel and Gregoraszczuk 2014). In contrast, all three parabens increased ERβ protein 
(ESR2 product) expression after 72 h treatment, but had no effects after 48 h, in MCF10A 
cells (Wrobel and Gregoraszczuk 2014). ICI 182,780 treatments seemed to have no effect 
on MCF10A cells (Wrobel and Gregoraszczuk 2014).  
 
2.4.2. Progesterone Receptor 
Progesterone receptor is another major receptor marker for patients being diagnosed with 
breast cancer (Harbeck, Penault-Llorca et al. 2019). Similar to that of estrogen, 
progesterone is a steroid hormone that influences the reproductive system and breast 
development, and PR functions to regulate transcription and cell proliferation (Cenciarini 
and Proietti 2019). PR mRNA expression is significantly increased by PP and BP after 24 
h treatments in both MCF7 and MCF10A cells (Wrobel and Gregoraszczuk 2014). 
Interestingly, however, MP and PP, but not BP, increased protein expression of PR in 
MCF7 cells, but not MCF10A cells (Wrobel and Gregoraszczuk 2014). (Wrobel and 
Gregoraszczuk 2014). Similarly, in vivo, MP and EP at 20, but not 4 mg/kg/day, induced a 
significant increase of PR mRNA expression in SD rats' uterine tissue (Sun, Yu et al. 2016).  
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2.4.3. Human Epidermal Growth Factor Receptor 
Parabens have been demonstrated to crosstalk with HER2 to promote oncogenic c-myc 
gene expression and proliferation of an ERα- and HER2-positive human BT-474 breast 
cancer cells in an ERα dependent manner (Pan, Yuan et al. 2016). HER is a family of 
transmembrane proteins that act as receptor tyrosine kinases PI3K/Akt signaling (Pan, 
Yuan et al. 2016). Activation of PI3K/Akt can lead to the phosphorylation of ERα, which 
enhances the affinity for binding of ER. Adding to the complexity, ERα has the ability to 
crosstalk with HER signaling, but the synergy is greatly dependent on the presence of ERα 
(Pan, Yuan et al. 2016).  
 
Akt activation via HER has the ability to affect c-myc expression. c-myc mRNA expression 
was enhanced by HER2 agonist heregulin (HRG) upon co-treatment with PP and BP in the 
BT-474 cells (Pan, Yuan et al. 2016). Interestingly, PP and BP at 10 µM without HRG 
appeared to induce a 10-20 fold increase of c-myc mRNA expression. Blocking ERα 
activation with an ER inhibitor, such as ICI 182,780, raloxifene, or tamoxifen, attenuated 
the synergistic effect of HRG and BP on c-Myc protein expression (Pan, Yuan et al. 2016). 
Moreover, HRG was demonstrated to lower the dose of BP required to promote the BT-
474 cell proliferation.  Chromatin Immunoprecipitation (ChIP) assays further demonstrated 
that BP and HRG synergistically recruit ERα transcription factors to the promoter region 
of the c-myc gene enhancing cellular proliferation which is attenuated by ER antagonists.  
 
2.4.4. Androgen and Glucocorticoid Receptor 
Androgen is another steroid present in women and functions primarily as testosterone, a 
precursor to estrogen. Glucocorticoids are steroid hormones that function to abrogate 
inflammation decreasing immune activity, to regulate electrolyte balance, and to regulate 
glucose metabolism (Kolsek, Gobec et al. 2015, Busada and Cidlowski 2017, Schiffer, 
Barnard et al. 2019). It has been shown that paraben (at 50 µM, verified as non-toxic to the 
cells) stimulated glucocorticoid receptor (GR) by activating mouse mammary tumor virus 
(MMTV) reporter in the MDA-kb2 cells, which are MDA-MB-453 cells that stably express 
MMTV luciferase reporter gene and high levels of GR and androgen receptor (Kolsek, 
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Gobec et al. 2015). Moreover, MP and EP showed anti-androgenic activities while BP 
showed androgenic activities by the MDA-kb2 MMTV reporter assay (Kolsek, Gobec et 
al. 2015).    
 
2.4.5. G-Protein Coupled Receptor 
Parabens have also been suspected to function through other pathways that are non-
genomic, which are more rapid. G-protein coupled estrogen receptor 1 (GPER1 or GPR30) 
is associated with the plasma membrane and acts through protein-kinase cascades such as 
ERK1/2 (Wrobel and Gregoraszczuk 2015). GPR30 mediated signaling regulates matrix 
metalloproteinases (MMPs), which are enzymes that function in the rearrangement of the 
microenvironment and involved in cancer metastasis. GPR30 is highly expressed in 
cancerous breast epithelial cells and breast tumors, especially those from patients who are 
resistant to ERα inhibitors, like tamoxifen (Ignatov, Ignatov et al. 2011). MP, PP, and BP 
at 20 nM upregulated GPR30 mRNA expression greater than estradiol in MCF7 cells after 
24 h and in MCF10A cells after 6 and 24 h (Wrobel and Gregoraszczuk 2015). 
Additionally, MP and PP increased GPR30 protein expression after 48 h in both MCF7 and 
MCF10A cells and after 72 h in MCF7 cells. Interestingly, only BP, but not MP or PP, 
increased GPR30 protein levels at 72 h in MCF10A cells (Wrobel and Gregoraszczuk 
2015).  It is well known that estrogen-GPR30 signaling activates a rapid response through 
the activation of ERK1/2 and cAMP/PKA. Whereas no tested parabens affected cAMP 
levels in either cell line, PP and BP increased phosphorylation of ERK1/2 in MCF-7 cells, 
whereas MP and BP, but not PP, increased phosphorylation of ERK1/2 in MCF-10A cells. 
This activation GPR30/ERK1/2 signaling pathway by parabens demonstrates an additional 
mechanism by which breast cancer cells proliferation and progression can be enhanced by 
parabens.  
 
2.5. Parabens Effect on Breast Cancer Progression 
The influence on breast cancer proliferation by parabens have been well-reviewed 
previously (Darbre and Harvey 2014). However, recent publications confirm previous 
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findings and elaborate on the mechanism by which parabens affect breast cancer initiation, 
proliferation, and metastasis.  
 
2.5.1. Mimic Estrogen in Inducing ER+ Breast Cancer Gene Expression 
As parabens are estrogenic, it is beneficial to identify if parabens elicit the same genomic 
response as estrogens. Not only does this confirm the estrogenic nature of parabens, but it 
could also unveil novel gene targets for breast cancer treatment. Using a set of 120 estrogen 
responsive genes, paraben (10 µM) induced expression profile was compared to that of 
estrogen (17-estradiol or E2) used at 10 nM in MCF7 cells. Among MP, EP, PP, and BP, 
significant correlations of expression profiles to that of E2 were observed for PP and BP 
(R = 0.74 and 0.60, respectively), indicating estrogenic effects of parabens in a manner that 
is dependent on alkyl chain length. PP and BP-induced expression profiles correlated 
significantly with the effects of E2 in genes coding for enzymes, signaling, proliferation, 
transcription, and transport, and others. However, profiles induced by PP and BP resembled 
each other more than that of estrogen (Terasaka, Inoue et al. 2006).  
 
To gain a full picture of how paraben regulates genes in comparison with that of E2 in 
MCF7 cells, the expression profiles of 19881 genes in MCF7 cells following a 7-day 
exposure to 5(10-4) M MP, 10-5 M n-BP and 10-8 M E2 were studied using the GE-
Am2ersham CodeLink 20 K human expression microarray system (Pugazhendhi, Sadler et 
al. 2007). Venn diagram showed that 2963 genes were changed by ≥ 2 fold by one or more 
treatment. Only 61 genes were induced and 198 genes were downregulated by all three 
treatments. The majority of genes were regulated by only one or two of the treatments, 
indicating that significant differences in MCF7 cells’ response to paraben and E2. For 
example, MP and BP upregulates interleukin 17 receptor B (IL17RB), otoferlin (OTOF), 
and prolactin receptor (PRLR), but suppresses ubiquitin D and adrenomedullin, similar to 
E2 (Pugazhendhi, Sadler et al. 2007). However, genes such as bruno-like5 RNA binding 
protein (CELF5), myeloid/lymphoid mixed-lineage leukemia 2 transcription factor 
(MLL2) and alanyl-tRNA synthetase like (AARSL) were upregulated more with paraben 
treatments (Pugazhendhi, Sadler et al. 2007). Analyzing the global gene expression 
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patterns demonstrated that even though some gene expression patterns are similar to E2, 
the alterations do not match perfectly.  
 
In addition to MCF7 cells, the estrogenic effects of pubertal exposure to 4 mg/kg bw/day 
MP or EP in a uterotrophic assay similar to human exposure levels in immature SD rats 
induced an upregulation of 138 genes and downregulation of 157 genes including estrogen-
responsive genes in the uteri of the rats by quantitative real-time RT-PCR  (Sun, Yu et al. 
2016). mRNA expression of icabp, itmap, CaBD-9k, and PR were increased by both MP 
and EP treatment (Sun, Yu et al. 2016). MP-induced globally upregulated genes include 
those functioning in DNA replication and regulation of cell cycle such as E2F transcription 
factor 1 (E2f1) (Gopalakrishnan, Teitelbaum et al. 2017). In contrast, MP globally 
downregulated genes function in immune response and interferon signaling pathways, 
including interferon regulatory factor (Irf7) (Gopalakrishnan, Teitelbaum et al. 2017).  
Therefore, parabens can enhance DNA replication while also diminishing the immune 
response setting the ideal conditions for proliferation. 
 
Moreover, the effects of paraben on gene expression of select cell cycle/apoptosis genes 
were compared with those of E2 in MCF7 and MCF-10A (Wrobel and Gregoraszczuk 
2014). At mRNA levels, estradiol-induced G1/S phase genes (cyclin D1, D3 and cyclin-
dependent kinase (CDK) 2 and 4), suppressed some cell cycle progression inhibitors and 
also induced pro-survival genes (BCL2) in both cell lines. Parabens did not alter cyclins 
expression, and MP and BP did not affect the select apoptotic genes in MCF-7 cells 
(Wrobel and Gregoraszczuk 2014). However, parabens induced a greater response in MCF-
10A cells, were MP, PP, and BP all increased cyclin D1, E1, CDK 4, and CDK 2 
expression, but suppress p21 expression (Wrobel and Gregoraszczuk 2014). 
 
2.5.2. Induce Genome Instability 
Genome instability refers to the genomic alterations cells acquire, leading to 
carcinogenesis. Genome instability includes base-pair mutations, insertions, deletions, or 
translocations of whole or fragmented chromosomes. These chromosomal aberrations 
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hinge upon double-strand breaks (DSB) and often times occur in tandem with mutated 
DNA repair genes, such as BRCA1 and BRCA2 (Duijf 2019). 
 
The findings that parabens promote both MCF7 and MCF10A cell growth promoted the 
study of genotoxicity studies by parabens. In vitro genotoxicity test and in vitro screening 
cytokinesis-block micronucleus (CBMN) tests using human lymphoblastoid TK6, mouse 
lymphoma L5178Y cells and human lymphocytes were performed (Finot, Kaddour et al. 
2017, Guzel Bayulken, Ayaz Tuylu et al. 2019). The use of MCF-10A cells is to model the 
effect of parabens on cells that are not cancerous, and parabens do increase the proliferation 
of these cells at 100 nM. However, there has not been much insight into the genotoxic 
effects of parabens on this cell type. EP, PP, and BP induce a genotoxic effect at high doses 
(50-500 μg/mL) on lymphocytes, which is associated with worse clinical outcomes in 
breast cancer patients (Finot, Kaddour et al. 2017, Guzel Bayulken, Ayaz Tuylu et al. 
2019). 
 
CBMN are miniature nuclei separate from the primary nucleus that contain desegregated 
chromosomes where extensive DNA damage occurs and can subsequently be incorporated 
back into the primary nucleus (Duijf 2019). L5178Y and TK6 cells had increased mutations 
at the thymidine kinase (tk) locus upon high dose treatment of EP for 3 h indicative 
resistance to apoptosis and inflicted a greater amount of CBMN at 120 μg/mL (Finot, 
Kaddour et al. 2017). At 24 h, BP, PP, and isopropylparaben (IPP) all induced greater 
numbers of CBMN at the highest dose of 100 μg/mL (Guzel Bayulken and Ayaz Tuylu 
2019). With a 48 h exposure, PP and BP caused greater CBMN formation at 50 and 100 
μg/mL (Guzel Bayulken and Ayaz Tuylu 2019). Shorter treatments were conducted in the 
presence of S9, a metabolic activator, generating an unknown set of metabolites. TK6 cells 
still had a significant CBMN presence after 26 h of treatment without S9, indicating EP’s 
genotoxic effect is independent of S9 metabolic conversion (Finot, Kaddour et al. 2017). 
Metabolite 4-hydroxybenzoic acid does not have the same CBMN formation effect as 
parabens and only causes the formation of CBMN at 500 μg/mL for 48 h (Guzel Bayulken, 
Ayaz Tuylu et al. 2019).  
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Telomere shortening is one determinant to demonstrate parabens’ influence in 
genotoxicity. A telomere is a nuclear protein that caps the chromosomes and prevents 
degradation or DNA damage. Telomere shortening leads end-to-end joining of adjacent 
chromosomes causing dicentric chromosomes. When these chromosomes undergo mitosis 
DNA breaks occur promoting genome instability (Duijf, P. et al. 2019). EP causes a 
decrease in fluorescence of telomere length in murine lymphoma cells (L5178Y) and 
human lymphoma cells (TK6) cells as compared to their control cells (murine bone 
marrow, human lymphoblastoid, and Burkitt lymphoma cells) using telomere staining and 
comparing total fluorescence intensity of metaphase chromosomes (Finot, Kaddour et al. 
2017). Loss of one telomere is the most significant disruption to telomere length upon EP 
treatment (Finot, Kaddour et al. 2017). Additionally, when controlling for age, the telomere 
length of paraben-exposed human lymphocytes was significantly shorter by both telomere 
loss and deletions than the paraben-unexposed lymphocytes (Finot, Kaddour et al. 2017). 
Therefore, parabens at higher doses (100-350 μg/mL) can affect telomere length. 
 
As mentioned previously, the incorporation of DSB into the genome initiates 
carcinogenesis if in a vulnerable DNA location (Kidane 2018, Jiang, Panda et al. 2019). 
γH2AX and 53BP1 foci have been identified as markers of the formation of DSB if 
localized to intra-chromosomal regions (Finot, Kaddour et al. 2017). Untreated L5178Y 
and TK6 cells had these markers distributed throughout the nuclei, but EP treatment leads 
to the localization of these foci at or near shortened or uncapped telomeres, indicating 
telomere shortening (Finot, Kaddour et al. 2017). Even though there have been no 
identifiable DSB, EP treatment of L5178Y cells demonstrated both clonal and sporadic 
dicentric chromosomes (12 and 13) and trisomy chromosomes (15 and 18) (Finot, Kaddour 
et al. 2017). EP treatment of TK6 cells has a greater amount of acentric chromosomes 
(Finot, Kaddour et al. 2017). 4-Hydroxybenzoic acid at 250-500 μg/mL dosages and PP, 
BP, and IBP at 50-100 μg/mL also led to the chromosomal aberrations, most commonly 
chromatid breaks (Guzel Bayulken and Ayaz Tuylu 2019, Guzel Bayulken, Ayaz Tuylu et 
al. 2019). Comet assay is the gold standard for analyzing DNA damage where the damaged 
DNA fragments migrate through electrophoresis faster than the undamaged DNA 
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developing a tail (Jiang, Panda et al. 2019). The length and intensity of the tail indicate the 
number of DSB (Jiang, Panda et al. 2019). Lastly, a comet assay was conducted to 
conclusively identify the presence of DSB in lymphocytes upon a 4-hydroxybenzoic acid 
treatment, and only the highest concentration (1000 μg/mL) had significant DNA damage 
compared to the solvent control (DMSO) (Guzel Bayulken, Ayaz Tuylu et al. 2019). 
However, 100 μM BP appeared to show protective properties against genotoxicity, but not 
cell proliferation induced by silver nanoparticles (Roszak, Domeradzka-Gajda et al. 2017). 
Therefore, parabens have the ability to induce genotoxicity, but only at doses higher than 
those from a typical environmental exposure; however, more studies at environmentally 
achievable doses are necessary for a realistic perspective on parabens-induced 
genotoxicity. 
 
2.5.3. Evoke Breast Cancer Proliferation 
Parabens at concentrations greater than 10 nM induce higher proliferation of cancerous 
epithelial cells (MCF7) with attenuation by the inhibition of ERα and ERβ (Okubo, 
Yokoyama et al. 2001, Lillo, Nichols et al. 2017). As mentioned previously, parabens and 
their metabolite p-hydroxybenzoic acid bind to ER as compared to other environmental 
phenols (Okubo, Yokoyama et al. 2001, Darbre, Byford et al. 2002, Pugazhendhi, Pope et 
al. 2005). The potency of the paraben effect on proliferation and binding competition 
correlated with their chain length and branching (Okubo, Yokoyama et al. 2001). Long, 
branched parabens have more potency and have the greatest binding affinity and rank from 
least to greatest as MP < EP < PP < IPP < BP and IBP. This affinity and potency ranking 
was confirmed for IBP, benzP, and p-hydroxybenzoic acid by competitive binding assays 
for ERα and ERβ (Okubo, Yokoyama et al. 2001, Darbre, Byford et al. 2002, Darbre, 
Byford et al. 2003, Pugazhendhi, Pope et al. 2005).  
 
Parabens also have the ability to enhance cellular proliferation in MCF10A cells, 
implicating parabens’ effects on breast carcinogenesis (Khanna and Darbre 2013, Darbre 
and Harvey 2014). Butylparaben at 0.5 mM MP, 50 μM PP, and 50 μM produced greater 
number and size of cell colonies and MP and PP induced significantly greater colony 
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formations (Khanna and Darbre 2013, Darbre and Harvey 2014). PP and BP maximum 
colony formation peaked at 5 μM; however, MP had twice this maximum at 0.5 mM, 
demonstrating that MP has the greatest effect on MCF10A cell growth (Khanna and Darbre 
2013).  
 
In vivo, MP significantly increases tumor growth of MCF-7 cells and patient-derived 
xenograft (PDX) breast tumor in immunocompromised female mice in comparison with 
the estrogen treatment (Lillo, Nichols et al. 2017). However, MDA-MB-231 
mammospheres treated with 10 nM MP for 10 days did not induce proliferation nor 
increase in tumor size, which confirmed previous reports of the non-prolific effect of 
parabens on these cells (Lillo, Nichols et al. 2017). MDA-MB-231 cells are representative 
of triple-negative breast cancer, which has no ER, PR, and HER2  expression, is the most 
aggressive and is the most difficult to treat. Therefore, this suggests that parabens promote 
both carcinogenesis and cancer proliferation in a hormone receptor-dependent manner at 
low doses. 
 
The mechanisms by which parabens promoted cell proliferation in normal or cancerous 
breast epithelial cells have been explored. It was reported that the paraben activated 
mitogenic ERK1/2 pathway through the activation of GPR30. PP and BP, but not MP, at 
20 nM caused phosphorylation of ERK1/2 upon 5 to 120 minutes of exposure in MCF7 
cells (Wrobel and Gregoraszczuk 2015). MP and BP, but not PP, at 20 nM also activated 
ERK1/2 in MCF10A cells. The phosphorylation of Akt was induced by PP but was 
significantly suppressed by BP in MCF7 cells (Wrobel and Gregoraszczuk 2015).  
 
Moreover, another study suggested that parabens may enhance proliferation through 
increasing aromatase (CYP19A1) expression. Aromatase functions in the conversion of 
androgens to estrogen, which is a hormone that increases cellular proliferation of estrogen 
responsive normal breast epithelial cells and breast cancer cells. Treatment of 20 nM MP 
and PP caused a greater expression of CYP19A1 mRNA and protein expression in MCF7 
cells; however, MP, PP, and BP decreased this expression in MCF10A cells below the 
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vehicle control (Wrobel and Gregoraszczuk 2013). Consistently, parabens also increased 
the production of estradiol in MCF7 cells and decreased MCF-10A cells estradiol 
production at a low concentration range (0.2 nM-200 nM) as compared to the high-dose (2 
µM), which secreted less estradiol (Wrobel and Gregoraszczuk 2013).  
 
2.6. Parabens Effect on Breast Cancer Metastasis 
The majority of diagnosed breast cancers are ER-positive and luminal A or B, which have 
effective adjuvant pharmaceutical treatment (Gao and Swain 2018). Luminal A breast 
cancers can be ER/PR+, HER2 negative and low levels of Ki67 (a marker of proliferation), 
and Luminal B is defined as ER/PR+, HER2 +/- and high levels of Ki67 (Gao and Swain 
2018). These cancerous epithelial cells can progress to mesenchymal-like cells typically 
found in basal-like, hormone-resistant, and advanced breast cancers commonly known as 
triple-negative breast cancer, the most deadly form of breast cancer. This process of 
dedifferentiation is called epithelial-to-mesenchymal transition (EMT) and also occurs in 
embryogenesis and wound healing (Macias and Hinck 2012, Lamouille, Xu et al. 2014). 
The phenotypical alterations demonstrating EMT include anchorage independence, 
polarization, migration, and invasion (Lamouille, Xu et al. 2014, Huang, Li et al. 2015). 
Once cells have undergone EMT, they are able to function as mesenchymal cells and more 
able to migrate through the basement membrane and into circulation leading to metastasis. 
 
2.6.1. Cell-Surface Transformation 
To begin the process of metastasis, the cancerous cells lose the expression of basement 
membrane attachment cell-cell contact proteins, such as E-cadherin and vimentin, 
characteristic of epithelial cells. Mesenchymal markers, such as fibronectin and N-cadherin 
begin to be expressed leading to alterations in the extracellular matrix. The shift of E-
cadherin to N-cadherin is linked with loss of cell-cell interaction and ultimately poor 
clinical outcomes (Lamouille, Xu et al. 2014, Huang, Li et al. 2015). MCF7 cells exposed 
to parabens showed the significant invasion of Matrigel and reduced the protein expression 
of E-cadherin and β-catenin with multiple treatments, indicative EMT (Darbre and Harvey 
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2014, Khanna, Dash et al. 2014). The mechanisms by which parabens reduced E-cadherin 
expression have not been elucidated. 
 
2.6.2. Stem Cell Markers 
EMT can also be confirmed by examining the markers of stem cells which indicate the 
dedifferentiation of cancerous cells to the mesenchymal state. A physiological level of MP 
(4.4 μg per day) caused an increase of tumor size from MCF-7 xenografts and ER+ PDX 
tumors. MP induced a shift to mesenchymal by upregulating mRNA expression of Nanog, 
Oct4, and ALDH1 in both MCF7 and PDX mammospheres (Lillo, Nichols et al. 2017). 
Interestingly, the pre-treatment of MCF7 cells with ER antagonist tamoxifen, a common 
therapy for ER (+) breast cancers, does not impede the MP induction of mammosphere size 
or NANOG protein expression (Lillo, Nichols et al. 2017). Therefore, it is likely that MP 
impacted mammosphere formation and NANOG protein expression through ER-
independent signaling pathways signaling.  
 
2.6.3. Cellular Migration and Invasion 
Disruption of tight junctions between the cells allows for tumor progression and metastasis, 
cellular migration and invasion (Lamouille, Xu et al. 2014). These structural changes 
induce stress and the formation of stress fibers, which provide structural strength to the 
malformed cell. A migratory property allows the cancerous cells to traverse the 
extracellular matrix for proliferation and nutrient acquisition. Once cells develop an 
invasive characteristic, they progress to intravasation where the cells are able to pass 
through the basement membrane and to survive in circulation (Semenza 2016).  
 
It has been reported that 50 µM BP induced matrix degradation and invasion of MCF7 in 
a 7-day treatment, whereas 0.5 mM MP, 50 µM PP and 50 µM BP promoted MCF7 cell 
migration and invasion in 20 weeks of treatment (Darbre and Harvey 2014, Khanna, Dash 
et al. 2014). Migratory effects by parabens also were demonstrated in other two estrogen-





Humans are exposed to parabens throughout life from personal care products, food, 
pharmaceuticals, industrialization, etc., and these parabens can be absorbed into 
circulation. Parabens can negatively affect many different hormone and endocrine-related 
processes. Specifically, parabens can influence breast cancer progression by binding and 
activating ERs and modulating the expression of ERs and other steroid-related receptors, 
such as PR, AR, and GPR30. Consequently, parabens can activate various signaling 
pathways ultimately leading to breast epithelial cell proliferation. Moreover, parabens have 
also been shown to encompass the ability to induce EMT, increase cell migration and 
invasion, characteristics critical for breast cancer metastasis. However, many of the studies 
tested parabens at very high doses, such as 50 μM. Therefore, further research is necessary 
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CHAPTER 3 : 
PARABENS INDUCE INFLAMMATION IN STROMAL 





3.1. Abstract  
Background: It is increasingly realized that breast stroma plays a critical role in breast 
carcinogenesis and breast cancer progression. Understanding the alterations that occur in 
the stromal cells in breast carcinogenesis can lead to novel and effective therapeutic or 
preventative strategies. Parabens are a group of 4-hydroxybenzoic acid esters, commonly 
found in pharmaceuticals, food, personal care products, and paper as anti-microbial agents. 
Studies have shown that parabens are estrogenic, act as endocrine disrupting chemicals in 
experimental animals, and can accumulate in higher amounts in the breast cancer samples. 
Therefore, we hypothesize that parabens may promote breast carcinogenesis by negatively 
modulating breast stroma nearby breast epithelial cells.  
 
Methods: 3T3-L1 murine and BRF human fibroblasts were exposed to the three most 
common parabens, methyl-, propyl-, and butylparaben (MP, PP, and BP) at 
environmentally relevant doses (0.02, 0.1, and 1 µM) for 6, 12, and 24 hours. Gene 
expression was determined by RT-PCR. 3T3-L1 CARΔ1 cells, which are engineered to 
express adenovirus receptors, were employed to study NF-κB activation followed by 
Western analysis of p-p65 and IκBα degradation, two critical events for NF-B signaling 
pathways. Lastly, paraben-treated fibroblast conditioned media was tested for their abilities 
to promote the proliferation of autobioluminescent MCF7 breast cancer cells.  
 
Results: A single exposure to all three parabens at the tested doses induced inflammatory 
gene IL-1β, MMP9, COX2, and CYP19A1 in both murine 3T3-L1 fibroblasts and human 
BRF cells. Consistently, all three parabens activate NF-B in both 3T3-L1 and BRF cells 
as demonstrated by the activation of NF-B reporter and phosphorylation of p65 and IBα 
degradation. Moreover, the conditioned media from paraben-treated 3T3-L1 fibroblasts 
and human BRF cells induced proliferation of breast cancer MCF7 cells.  
 
Conclusion: Parabens may play important roles in breast cancer progression by inducing 
inflammation in breast stromal fibroblasts.   
38 
3.2. Introduction 
Breast cancer remains the second leading cause of cancer mortality in women within the 
US behind lung and bronchial cancers (ACS 2017). The tumor microenvironment or stroma 
impacts breast cancer progression by enabling proliferative signaling, activating 
angiogenesis, allowing invasion and metastasis via extracellular matrix (ECM) 
remodeling, etc. through the communication of secreted chemokines and cytokines 
(Hanahan 2011). Tumor stroma is composed of a variety of cell types, including 
adipocytes, fibroblasts, macrophage, neutrophils, mast cells, and endothelial cell, all of 
which cross-talk with each other and with nearby breast epithelial cells to promote 
carcinogenesis and cancer progression (Soysal, Tzankov et al. 2015, Lee, Lee et al. 2018).  
 
Chronic inflammation has been recognized for its association with an increased risk of 
cancer development. Stromal inflammation is thought to activate dormant tumors or initiate 
tumorigenesis in transplanted primary epithelial cells, a process called stromal induction 
(Radisky and Radisky 2007).  The stroma is densely populated with fibroblasts, and these 
fibroblasts can enable tumor proliferation, sustain elevated pro-inflammatory gene 
expression, accommodate metastasis, etc. (Lim and Moon 2016). Fibroblasts are typically 
activated by wound healing or tissue injury, where they begin to play a role in inflammation 
in the recruitment of immune cells to repair the damage (Kalluri 2016). A tumor comprises 
a similar response to that of tissue damage or an injury with the activation of stromal 
fibroblasts that release inflammatory cytokines for healing (Kalluri 2016). However, the 
stroma consists of many other different cell types, including adipocytes, macrophage, mast 
cells, endothelial cells, etc., and each cell type begins secreting different factors into the 
stroma which are all able to have autocrine or paracrine action (Semenza 2016). Somehow, 
the communication between these cells begins to permit the growth of cancerous cells and 
begin to work in collaboration with cancer. Therefore, it is critically important to 
understand the complex interactions between these stromal cells and the epithelial cells.  
 
The inflammatory response by fibroblasts is critical in the communication with the 
cancerous epithelial cells (Lim and Moon 2016, Balachander, Talukdar et al. 2018).  
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Cyclooxygenase-2 (COX2) has been implicated in the development of various cancers, 
including gastric, breast, lung, esophageal, and colon cancer (Li, Zheng et al. 2016, Sano, 
Kogashiwa et al. 2018). COX2 is overexpressed in aggressive breast tumors associated 
with poor prognosis and survivability, and knockout of COX2 in MCF7 breast cancer 
epithelial cells attenuates proliferation (Denkert, Winzer et al. 2004, Brown, Subbaramaiah 
et al. 2008, Han, Yang et al. 2014). Prostaglandin E2 (PGE2), a downstream product of 
COX2, enhances tumor growth through inflammation, leading to angiogenesis, 
invasiveness, and evading cell death (Li, Shan et al. 2015). Interleukin-1 beta (IL1β), one 
prominent cytokine released into the inflamed stroma, has been shown to increase 
invasiveness and metastasis of breast tumors and correlates with worse prognosis (Brown 
2014, Stender, Nwachukwu et al. 2017). Additionally, IL1β contributes to endocrine and 
chemotherapy resistance in ER+ breast cancers through activation of IKKβ, upstream of 
NF-κB signaling (Stender, Nwachukwu et al. 2017).  
 
Moreover, proteases within the stroma have been recognized as influential in the growth 
of tumors. Matrix metalloproteinases (MMP) are enzymes that breakdown the ECM, 
providing space for tumor growth, passages for invasion and metastasis, and are 
overexpressed in many breast cancers (Zaremba-Czogalla, Hryniewicz-Jankowska et al. 
2018). MMP-9 functions in digestion of ECM proteins, including collagen, fibronectin, 
and laminin; in addition, MMP-9 can also degrade other non-matrix signaling proteins 
within the stroma (Radisky and Radisky 2007). Interestingly, MMP-9 is a target of NF-κB 
activation and is associated with COX2 activity via PGE2 production (Li 2012, Chimal-
Ramirez, Espinoza-Sanchez et al. 2013).  
 
It is well recognized that environmental exposures contribute to the development of many 
chronic diseases, including cancer (Cui, Balshaw et al. 2016). Endocrine disrupting 
chemicals (EDC) are industrial chemicals utilized to enhance product sustainability and 
extend shelf-life but have been identified to dysregulate endocrine systems, causing 
adverse health outcomes (Darbre 2006, Burks, Pashos et al. 2017). Parabens are alkyl esters 
of p-hydroxybenzoic acid incorporated into personal care products, pharmaceuticals, food 
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packaging, and paper products for their anti-microbial and anti-fungal properties. The most 
common parabens used in the commercial products and therefore often being detected in 
human biological samples are MP, PP, and BP (Figure 3.1.) (Giulivo, Lopez de Alda et al. 
2016).   
 
Even though parabens have been classified as weak EDCs, previous studies have 
demonstrated their ability to bind hormone receptors at low-dose exposures, enhancement 
of estrogenicity, and promotion of proliferation, invasion, and migration of breast epithelial 
cells (Darbre and Harvey 2014). Moreover, total parabens have been detected within 
normal breast tissue at an average concentration of 85 ng/g of tissue, indicating parabens 
proximity to potentially cancerous epithelial cells (Barr, Metaxas et al. 2012). Furthermore, 
parabens have been detected in higher amounts in breast cancer samples than their normal 
breast tissue controls, ranging from 17.3 ng/g of tissue to 115 ng/g of tissue (Darbre, 
Aljarrah et al. 2004). To this end, parabens have been shown to promote breast epithelial 
cell growth; however, it is not clear whether parabens also negatively affect breast stroma 
(Darbre and Harvey 2008).    
 
The objective of this study was to investigate the inflammatory effects of common parabens 
(MP, PP, and BP) at environmentally achievable doses (0.02, 0.1, and 1 µM) on the stromal 
fibroblasts from both murine and human origins and the ability of exposed fibroblasts to 
enhance breast cancer cell proliferation. We show that parabens induce the upregulation of 
inflammatory genes (COX2 and IL1β), ECM remodeling gene MMP-9 and aromatase gene 
CYP19A1 by activating the NF-κB signaling pathway. We further demonstrate the 
conditioned media (CM) collected from paraben-exposed fibroblasts enhanced MCF7 
breast cancer cell proliferation. Our study demonstrates that common paraben at 
environmentally achievable doses promotes pro-inflammatory gene expression in the 
fibroblasts of the stroma and leads to enhanced breast cancer proliferation. 
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3.3. Materials and Methods 
3.3.1. Reagents  
Dimethyl sulfoxide; methyl-, propyl-, and butylparaben were from Acros Organics (>99%, 
Thermo Fisher Scientific, Pittsburg, PA). Caffeic acid phenethyl ester (CAPE) was ordered 
from Tocris Bioscience (Minneapolis, MN). Ultra-pure lipopolysaccharide (LPS) was from 
List Biological Laboratories (Campbell, CA). Phospho-NF-κB p65 (Ser536) (no. 3033) 
and NF-κB -p65 (D14E12) XP (no. 8242) were purchased from Cell Signaling Technology. 
IκBα (C-21) (sc-371) was purchased from Santa Cruz Biotechnology. Anti-β-actin (AC-
15) (no. A1978) was from Sigma-Aldrich. Neomycin (G-418) was purchased from 
Research Products Incorporated (Mount Prospect, IL). 
 
3.3.2. Cell Culture 
Murine 3T3-L1 fibroblasts (ATCC, Manassas, VA) were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 10% calf serum (HyClone).  Murine 3T3-L1 
coxsackievirus and adenovirus receptor (CARΔ1) cells were a gift from Dr. Orlicky 
(Orlicky DJ 2001) and were grown in DMEM containing 10% fetal bovine serum (FBS) 
(Atlanta Biological, Flowery Branch, GA).  Human subcutaneous breast fat preadipocytes 
(BRF) (Zenbio, NC) were grown in Preadipocyte Medium (PM-1) according to the 
manufacturer’s instructions (Zenbio, NC). Human Autobioluminescent MCF7 cells were a 
gift from Dr. Ripp ( 490 BioTech, Inc., Knoxville, TN) (Xu, Ripp et al. 2014) and were 
grown in DMEM 10% FBS with G-418. All are grown in 5% CO2, 37
oC conditions. 
 
3.3.3. Immortalization of Primary BRF Cells 
Immortalization of primary BRF cells was achieved by infecting the cells with lentivirus 
encoding the SV40LT antigen. SV40LT antigen was first cloned into lentivirus expressing 
vector carrying the neomycin phosphotransferase gene (Alwin Prem Anand, Gowri Sankar 
et al. 2012).  To generate lentivirus particles, SV40LT vector was co-transfected with 
packaging (psPAX2) and envelope (pMD2.G) vectors (Addgene; Boston, MA) in 
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HEK293T cells (GeneCopoeia, Inc; Rockville, MD) using FuGENE® HD transfection 
reagent (Promega Corporation; Madison, WI) following manufacturer’s guidelines and 
then used to infect BRF cells. Stable cell lines were selected using G-418 antibiotic (300 
µg/ml) for two weeks. 
 
3.3.4. Paraben Treatment 
To detect the inflammatory effects of low-dose paraben on 3T3-L1 or BRF fibroblasts, a 
single exposure  of 0.02, 0.10, or 1.0 μM methyl-, propyl-, or butylparaben was 
administered in low-serum conditions, 0.25% calf serum (HyClone) for 3T3-L1 cells and 
1% charcoal-stripped fetal bovine serum (CS-FBS) (HyClone) for BRF cells.  DMSO and 
LPS were used as vehicle control and positive control, respectively. 
 
3.3.5. RNA and Quantitative Real-Time PCR  
Total RNA was prepared from fibroblasts using TRIzol (Invitrogen Coorporation, 
Carlsbad, CA) following the manufacturer’s protocol. Total RNA quantity was measured 
using NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, 
DE). Reverse transcription was conducted utilizing High-Capacity cDNA Reverse 
Transcription kit (Thermo Fisher Scientific) following the manufacturer’s protocol. mRNA 
expression of fibroblast inflammation markers and housekeeping gene 36B4 (Table 1) were 
measured quantitatively utilizing PowerUp SYBR Green Master Mix (Thermo Fisher 
Scientific) and were analyzed in a 96-well template via an ABI 7300 HT Real-Time PCR 
System with cycle conditions of 50oC 2 min, 95 oC 2 min, and 40 cycles of 95oC for 
15s/60oC for 1 min. The relative gene expression was calculated utilizing a 2(-ΔΔCt) method 
and normalized against 36B4. 
 
3.3.6. Reporter Gene Assays 
3T3-L1 CARΔ1 and BRF fibroblasts were seeded in a 24-well plate format and infected 
with adenovirus encoding NF-κB-Luc reporter gene and adenovirus encoding β-
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galactosidase (β-gal) control plasmid for 15 h, as described previously (Purohit, Hu et al. 
2013). The cells were probed with various parabens for 12 h. The cell lysate was prepared 
utilizing Reporter Lysis 5X Buffer (Promega). Reporter luciferase activity was measured 
using GloMax Luminometer (Promega, Madison, WI) and normalized by β-gal expression. 
 
3.3.7. Western Blot Analysis 
Total cell lysates were prepared and protein concentrations measured by Pierce BCA 
protein assay kit (Thermo Fisher Scientific). 20-40 μg of total cell lysate were run through 
a polyacrylamide gel and transferred to polyvinylidene difluoride membrane (Bio-Rad). 
The membrane was blocked in 20 mM Tris-HCl, 137 mM NaCl, and 0.1% Tween 20 (pH 
7.4) containing 5% nonfat milk or 5% bovine serum albumin (BSA). The membrane was 
immunoblotted with primary antibodies at 4 oC overnight followed by secondary antibody 
conjugated with horseradish peroxidase. The signal was detected utilizing SuperSignal 
West Pico PLUS Chemiluminescent Substrate (Thermo Scientific), HyBlot CL 
autoradiography film (Denville Scientific), and a Konica SRX-101A film processor. 
Quantification by densitometry was conducted using ImageJ software. 
 
3.3.8. Conditioned Media Collection 
3T3-L1 and BRF fibroblasts were seeded into 60 mm dishes. Each plate of cells was treated 
with MP, PP, BP (each at 1 µM) or controls (DMSO or LPS) in 5% CS-FBS. After 72 h or 
10 days, the treatment media was removed, and the cells were washed twice with phenol-
red free (PRF) media (HyClone) to remove residual parabens. To collect CM, cells were 
then cultured for 48 h in PRF media with 5% CS-FBS and penicillin and streptomycin. 
After 48 h, the media was collected and centrifuged at 600 rpm for 5 minutes. The 
supernatant was transferred into a fresh tube and stored at 4oC before use.  
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3.3.9. Bioluminescent Imaging  
Autobioluminescent MCF7 cells were plated at 30% confluency in quadruplicate wells of 
a 24-well opaque, clear bottom plate (Labnet/Corning Inc., Cary, NC). After attachment 
overnight, MCF7 cells were washed with PRF media and treated with CM: fresh media in 
a 1:1 ratio. Treatment persisted for 7 days with changing CM at day 4. On day 7, plates 
were transferred to CCD-based IVIS Lumina imaging system (PerkinElmer). 
Autobioluminescent readings were acquired 3 times at 10 min intervals according to the 
manufacturer’s instructions. 
 
3.3.10. Statistical Analysis 
All data are presented as means + SE. Measurements were performed in triplicates unless 
otherwise indicated Statistical analysis was performed using SigmaPlot 14.0 (Systat 
Software). One-way ANOVA on ranks or one-way ANOVA with repeated measures 
followed by multiple comparison tests (Student-Newman-Keuls method) were used to 
determine the differences between treatment groups or time points. Student’s t-tests were 
conducted to evaluate LPS compared to the control. The level of significance was set at P 
< 0.05. The effects of treatment and plate location on fold change of average radiance were 
analyzed using two-way ANOVA analysis for each time point in 3T3-L1 and human 
BRF fibroblasts.Post hoc multiple comparisons were performed with Tukey’s adjustment. 
Statistical significance was identified at the level of 0.05. Analyses were conducted in SAS 
9.4 TS1M4 for Windows 64x (SAS institute Inc., Cary, NC). 
 
3.4. Results 
3.4.1. Parabens Induce mRNA Expression of Inflammatory Genes and CYP19A1 in 
Murine and Human BRF Fibroblasts 
3T3-L1 fibroblasts were exposed to MP, PP, or BP or their vehicle control (DMSO) at 
0.02, 0.1, or 1 µM for 6, 12, or 24 h. LPS was included as a positive control.  The 
inflammatory response to parabens differs depending on the length of the side chain, dose, 
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and time of exposure. All three tested parabens significantly upregulated inflammatory Il1β 
mRNA expression in 3T3-L1 fibroblasts. Compared to DMSO, 0.1 µM MP increased the 
maximal 2.5 fold of Il1β mRNA expression at 6 h (p<0.05) but had minimal effects at 12 
or 24 h of exposure (Figure 3.2.A), where 0.1 µM PP increased ~ 2 fold of Il1β mRNA 
expression at 6 h (p<0.05), increased to ~ 3 fold at 12 h and maintained at 1.5 fold at 24 h 
(p<0.001) of exposure (Figure 3.2.A). Butylparaben increased greater than 5 fold Il1β 
mRNA expression at 0.1 and 1 µM at 6 h. The increased levels were maintained at 12 h, 
but dropped at 24 h by 0.1 µM whereas gradually increased and reached the maximal 12 
fold at 24 h of exposure by 1 µM (p<0.05) (Figure 3.2.A). In contrast, the maximal 7 fold 
Il1β mRNA level by LPS was observed at 12 h and decreased to 3.5 fold at 24 h of exposure 
(Figure 3.2.A).  
 
In addition to Il1β, we also examined Mmp-9 mRNA expression, a key MMP in matrix 
remodeling in breast cancer growth. Even though LPS significantly upregulated Mmp-9 
mRNA expression at 6, 12, and 24 h exposure, there is not as great of an influence by 
parabens except that MP increased 1.5 fold at 6 h by 0.1 µM and PP increased 1.5 fold at 
12 h by 1 µM compared to the vehicle control (Figure 3.2.B). Butylparaben had increased 
Mmp-9 expression 2 fold at 6 h by both 0.1 and 1 µM (p<0.01). We examined the effects 
of parabens on Cox2 mRNA expression in fibroblasts as COX2 upregulation is greatly 
associated with the progression of many cancers, including breast cancer. All three paraben 
significantly upregulated Cox2 mRNA expression at 24 h (p<0.05) with BP reaching a 
maximum of 4.5 fold at 1 µM (p<0.05) compared to the control. In contrast, LPS increased 
1.8 fold of Cox2 mRNA expression at 12 h and maintained the level at 24 h (p<0.05) 
(Figure 3.2.C). 
 
Lastly, we analyzed mRNA expression of Cyp19a1, the enzyme responsible for the 
conversion of androstenedione and estrone to estrogen (Gerard and Brown 2018). All 
parabens tested, PP and BP in particular, significantly upregulated Cyp19a1 mRNA 
expression. MP at 0.1 µM significantly induced at 6 h (p<0.05). PP at concentrations 
greater than 0.1 µM significantly induced Cyp19a1 mRNA at all tested time points 
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(p<0.01), and induced significant upregulation by all tested concentrations at 24 h (p<0.05).  
All BP concentrations significantly upregulated Cyp19a1 mRNA expression at 6 h 
(p<0.05), and 12 h. At 24 h, BP greater than 0.1 µM concentrations increase expression 
(p<0.01) with maximal expression of 13 fold 1 µM compared to the vehicle control. In 
contrast, LPS only increased ~ 2-3 fold of Cyp19a1 mRNA expression at 12 and 24 h 
exposure (p<0.001) (Figure 3.2.D). 
 
Similarly to murine fibroblasts, immortalized BRF also responded to all three tested 
parabens, depending on the length of the side chain, dose, and time of exposure (Figure 
3.3.). MP induced maximal ~ 2 fold of IL1β mRNA expression at 12 h at 0.1 and 1 µM 
(p<0.05) and had no effects at 24 h in human immortalized BRF fibroblasts (Figure 3.3.A). 
Interestingly, low doses (0.02 and 0.1 µM), but not a high dose (1 µM), of PP induced ~ 2 
fold of IL1β mRNA at 6 h (p<0.01) and had lesser effects at 12 or 24 h of exposure (Figure 
3.3.A). However, at 24 h high dose PP induced the greatest response (p<0.01). 
Butylparaben only induced ~ 1.6 fold of Il1β mRNA at 12 h at the low dose of 0.02 µM 
(p<0.05) (Figure 3.3.A). In contrast, LPS induced a maximal 3.5 fold of Il1β mRNA 
expression at 12 h and a lesser fold increase at 24 h (Figure 3.3.A).  
 
In contrast, all three parabens induced more robust responses of MMP-9 in human BRF 
cells. Compared to the DMSO, MP induced ~ 2.5 fold of MMP-9 mRNA expression at 6 h 
by 0.02 µM and ~ 4 fold by 0.10 µM (p<0.05), reaching 5 fold at 12 h at 0.1 µM. At 1 µM, 
MP induced ~ 4 fold of MMP-9 mRNA expression at 12 h and maintained the level at 24 
h (Figure 3.3.B). Propylparaben dose-dependently increased MMP-9 mRNA, reaching 4.5 
fold at 1 µM, at 6 h (p<0.05). This dose-dependent response subsided at 12 and 24 h. 
Butylparaben had an inverse dose-dependent response with 0.02 µM increasing gene 
expression the most (p<0.01) at 6 h. Low dose BP maintained the most significant response 
at 12 h, but this enhancement subsided by 24 h. LPS only induced a minimal response of 
MMP-9 in human BRF cells (Figure 3.3.B).  
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Propyl- and butylparaben also significantly induced COX2 mRNA expression (Figure 
3.3.C). MP induced ~1.5 fold of COX2 mRNA expression at 0.02 µM at 6 h (p<0.01) and 
induced similar increases at 0.1 and 1 µM at 12 h (Figure 3.3.C). PP induced a maximal 
2.5 fold of COX2 mRNA at lower doses of 0.02 (p<0.05) and 0.1 µM (p<0.01) at 6 h, which 
were not maintained at 12 and 24 h. At 1 µM, PP induced a maximal 2.3 fold at 24 h 
(p<0.05) (Figure 3.3.C). BP induced a ~ 2.3 fold of COX2 mRNA at 1 µM at 6 h and 24 h 
(p<0.05). BP also induced a maximal of 2 fold at 0.02 µM at 24 h (p<0.01). In comparison, 
LPS induced a modest increase of COX2 mRNA at 6 h and reached the maximal 2 fold at 
24 h in human BRF cells (p<0.05) (Figure 3.3.C). 
 
Lastly, CYP19A1 mRNA expression was significantly upregulated by all three tested 
parabens at 6 h. However, at 12 h only MP induced significant upregulation and PP at 24 
h (p<0.05). Propylparaben increased CYP1A1 to ~ 2 fold at 0.1 µM at 12 h compared to 
the DMSO (p<0.05). Propylparaben induced most significant response with a ~ 12 fold 
increase at 0.02 µM at 6 h (p<0.05). All doses of BP increased CYP19A1 mRNA expression 
at 6 h with 0.1 µM reaching ~ 10 fold (p<0.05). Similarly, LPS induced a ~ 2 fold increase 
of CYP19A1 mRNA expression at 6 h which subsided over 12 and 24 h in human BRF 
fibroblasts (Figure 3.3.D).  
 
3.4.2. Parabens Activate NF-κB Signaling in Murine and Human Fibroblasts   
Next, we investigated the effects of paraben on the NF-κB signaling pathway, which is 
critical signaling that drives inflammatory gene expression (Li and Verma 2002). First, we 
investigated NF-κB activation using NF-κB-responsive luciferase reporter assays where 
fibroblasts were transiently infected with adenovirus encoding an NF-κB-Luc receptor. At 
1 µM, all three parabens activated NF-κB in 3T3-L1 cells with increasing potency, 
correlating with the length of the linear alkyl chain (MP < PP  BP) (Figure 3.4.A, left 
panel). To confirm the findings of the reporter assays, we also tested LPS activation with 
or without pre-treatment of an NF-κB inhibitor CAPE. LPS induced ~3 fold of NF-κB 
activation, which was significantly attenuated by CAPE (Figure 3.4.A, right panel). Similar 
to the gene expression results, MP and PP induced significant NF-κB activation in human 
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BRF fibroblasts at a lower dose of 0.02 µM (p<0.05 for MP and p<0.05 for PP), compared 
to murine 3T3-L1 cells (Figure 3.4.B). In contrast, LPS induced 3.5 fold of NF-κB 
activation (p<0.01) in human BRF fibroblasts. 
 
We further confirmed paraben-induced NF-κB activation in 3T3-L1 fibroblasts by 
analyzing the phosphorylation of p65 and degradation of IκBα, two key events leading to 
NF-κB activation (Li and Verma 2002) with treatment of DMSO (Figure 3.5.A), 1 μM BP 
(Figure 3.5.B), or LPS (Figure 3.5.C) in a time-dependent manner. Quantification 
comparing 1 μM BP to its own time 0 shows the degradation of IκBα (Figure 3.5.D) and 
phosphorylation of p65 (Figure 3.5.E). At 15 minutes, 1 µM BP significantly degraded 
IκBα compared to the zero time point (p<0.001) and p65 phosphorylation was enhanced at 
30 minutes (p<0.001). When normalizing the BP NF-B activation to the associated 
DMSO, similar trends in IκBα and p-p65 protein expression occurred with degradation 
beginning at 15 minute and phosphorylation at 30 minutes (Figure 3.5.F). Moreover, 
paraben induced NF-κB activation as measured by these two events in the BRF cells with 
treatment of DMSO (Figure 3.6.A), 1 μM MP (Figure 3.6.B), or LPS (Figure 3.6.C) in a 
time-dependent manner. Quantification of IκBα degradation showed LPS induced NF-B 
activation within 5 minutes of treatment, and 1 μM MP induced NF-B activation at 30 
minutes (Figure 3.6.D), similar to the murine response. Additionally, phosphorylation of 
p65 quantification demonstrates a drastic NF-B activation by LPS beginning at 15 
minutes and minimal response to 1 μM MP beginning at 5 minutes in human BRF 
fibroblasts (Figure 3.6.E). When normalizing MP NF-B activation with DMSO, a change 
in degradation profile occurred, but IκBα still degraded at 30 minutes and p65 had greatest 
phosphorylation at 90 minutes (Figure 3.7.F). 
 
3.4.3. Conditioned Media from Parabens-Treated Fibroblasts Regulates Breast Cancer 
Cell Proliferation 
To explore the effects of paraben exposure on stromal induction and cancer progression, 
we evaluated the effects of the conditioned media (CM) collected from paraben-treated 
fibroblasts on the proliferation of human breast cancer MCF7 cells. We evaluated CM 
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collected after short-term (72 h) and long-term (10 day) exposure of parabens on both 3T3-
L1 and BRF fibroblasts. The CM was then used to induce the proliferation of 
autobioluminescent MCF7 cells without the presence of paraben. At 72 h of paraben 
exposure to 3T3-L1 cells, MP induced greater proliferation of MCF7 cells compared to 
that of the other parabens; however, parabens elicit less MCF7 proliferation than the 
vehicle control (DMSO) (Figure 3.7.A).  However, CM from 10-days exposure to PP led 
to significantly increased proliferation of MCF7 cell (p < 0.01) compared to DMSO (Figure 
3.7.B). Interestingly, MCF7 cells have significantly increased proliferation after exposure 
to the CM collected from 72 h exposure to all three parabens in human BRF fibroblast (p 
< 0.001) (Figure 3.7.C). None of the CM from 10 days exposure in human BRF cells 
significantly induced MCF proliferation compared to DMSO, although the CM from BP 
induced more proliferation than that from MP, but not PP(p<0.01) (Figure 3.7.D).  
 
3.5. Discussion and Conclusion 
To our knowledge, our study is the first study that demonstrates parabens at environmental 
achievable doses activate the NF-κB signaling pathway and induce inflammatory gene 
expression in both murine and human stromal fibroblasts derived from breast fat. Using 
conditioned media, we demonstrate that the inflammatory response stimulated by low-dose 
parabens in stromal fibroblasts promotes breast cancer cell growth. Our results, therefore, 
suggest that typical exposure to parabens from the environment can elicit a pro-
inflammatory response in the breast stromal fibroblasts, which then stimulate nearby 
cancerous breast epithelial cells to proliferate. 
 
Parabens are ubiquitously present in the environment due to their properties as an anti-
microbial chemical and their preservative nature. These EDCs are absorbed dermally or 
ingested daily from a variety of different sources, including personal care products such as 
lotions, cosmetics, deodorants, and hair products; pharmaceuticals; food; etc. (Darbre and 
Harvey 2014). Once absorbed, parabens are distributed throughout the body and have been 
detected intact in blood, breast milk, placenta, and urine (Sandanger, Huber et al. 2011, 
Kolatorova 2017, Shen, Liang et al. 2017). The intakes of parabens from food range from 
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207-940 ng/kg body weight. However, absorption from personal care products ranges from 
31-766 µg/kg body weight (Darbre and Harvey 2014). An individual is exposed to parabens 
multiple times per day through every consumption or application of product containing the 
chemical. Unconjugated parabens are present in human serum within 5 h of absorption, 
and conjugated parabens can remain in human serum for 24 h (Shin, Shin et al. 2019). 
Therefore, we tested the effects of parabens at 6 h of exposure finding that they induce an 
inflammatory response. Additionally, we found that the inflammatory response is sustained 
as the fibroblasts are exposed to parabens for 12 and 24 h. Therefore, continual exposure 
to parabens throughout a day maintaining a free paraben presence in the serum for 12 or 
24 h can also lead to stromal inflammation.  
 
Parabens have been implicated in a variety of different diseases, including obesity, fertility, 
menstruation, and cancer (Hu, Chen et al. 2013, Smith, Souter et al. 2013, Darbre and 
Harvey 2014, Nishihama, Yoshinaga et al. 2016). Many of these diseases could be a result 
of parabens’ estrogenic properties, which have been well characterized (Lange, Kuch et al. 
2014). More specifically, parabens utilize a variety of signaling pathways to elicit these 
estrogenic effects including ERK1/2 and Akt signaling associated with ERα, ERβ, HER, 
GR, and other receptors (Wrobel and Gregoraszczuk 2014, Sun, Yu et al. 2016) (Kolsek, 
Gobec et al. 2015, Wrobel and Gregoraszczuk 2015, Pan, Yuan et al. 2016). Through these 
pathways, parabens have been reported to directly promote breast cancer cell proliferation, 
mammosphere formation, epithelial to mesenchymal transitions, and metastasis (Khanna 
and Darbre 2013, Darbre and Harvey 2014, Khanna, Dash et al. 2014, Lillo, Nichols et al. 
2017).  
 
As it is well recognized that breast cancer survival requires cooperation between breast 
cancer cells and the surrounding stroma (Hanahan 2011). Our findings add to the current 
literature by demonstrating parabens’ abilities to induce an inflammatory response in 
stromal fibroblasts, leading to a toxic microenvironment that can stimulate breast cancer 
cell growth. The inflamed stroma is thought to play critical roles in the breast cancer 
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development as it is shown that the tumor cells cannot survive if a tumor is removed from 
inflammation translocated to a normal stroma (Bussard, Mutkus et al. 2016).  
  
The stroma is composed of a variety of different cell types, including fibroblasts, 
adipocytes, immune cells, endothelial cells, etc.; each plays different roles in tissue 
homeostasis (Bussard, Mutkus et al. 2016). Stromal fibroblasts are the most abundant cell 
type in the stroma and are versatile as they act as precursors to various mesenchymal cell 
types, chondrocytes, adipocytes, myocytes, and endothelial cells (Kalluri 2016). These 
cells are activated during the wound healing response as well as response in tissue damages 
caused by tumors (Kalluri 2016, da Cunha, Domingos et al. 2019). Once activated, 
fibroblasts begin to secrete growth factors, microRNAs, cytokines and chemokines among 
other factors in both autocrine and paracrine fashion, leading to tumor-stromal cell and 
stromal cell-stromal cell crosstalk resulting in cancer progression and epithelial-
mesenchymal transitions (da Cunha, Domingos et al. 2019). Additionally, fibroblasts 
release of MMPs promoting the restructuring of the extracellular matrix proteins, including 
collagens, hyaluronic acid, laminins and fibronectin enabling cancerous cells growth and 
metastasis (da Cunha, Domingos et al. 2019). Therefore, the secretome contributions from 
activated fibroblasts can function to promote cancer progression. 
 
In this study, we have attempted to address the inflammatory effects of common parabens 
at environmentally achievable doses on stromal fibroblasts and the subsequent ability of 
exposed fibroblasts to enhance breast cancer cell proliferation. Our results indicate that 
parabens at low concentrations upregulate the mRNA expression of Cox2, Il1β, and MMP-
9 dependent on the type, dose, and exposure time of parabens. In murine fibroblasts, 
parabens enhanced the inflammatory response correlating with the increasing length of the 
linear alkyl side-chain (MP < PP < BP), where BP consistently generated the most 
significant response over time. In contrast, human fibroblasts' inflammatory response 
correlates with the decreasing length of the linear alkyl side-chain (BP < PP < MP). 
Methylparaben and PP provoke a higher fold and more sustainable inflammatory response 
than that of BP in the human BRF cells. Interestingly, MP is the type of paraben most 
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common in the environment and present in most abundance in the systemic fluids, making 
it the greatest risk in inducing inflammation in human breast fibroblasts (Greige-Gerges, 
Kaissi et al. 2013).  
 
These results of increase mRNA expression of inflammatory markers are consistent with 
the activation of NF-κB reporter and signaling pathways by paraben treatment. However, 
we did not address the other signaling pathways that parabens are known to influence. 
Some of the variability in gene expression patterns observed could be a result of activating 
the intricate network of signaling pathways that lead to activation of NF-B. An NF-κB 
signaling pathway is critical in mediating inflammatory response (da Cunha, Domingos et 
al. 2019). Two critical downstream events that lead to NF-B activation are IBα 
degradation and phosphorylation of p65 (Hayden and Ghosh 2004). The three markers 
identified to be upregulated by paraben exposure are all connected to the NF-κB signaling 
pathway (Li 2012, Kalluri 2016, Suman, Sharma et al. 2016, Tulotta and Ottewell 2018). 
Together, our results suggest that selected parabens at environmental achievable doses 
induced inflammatory gene expressions in both murine and human breast derived 
fibroblasts, which is accompanied by activation of NF-B signaling pathways even though 
we do not conclusively show parabens directly activate NF-B signaling. Future studies 
are warranted to confirm these results by conducting in vitro studies and in vivo studies 
using NF-κB knockdown or inhibitors to see if NF-B is required in paraben-induced 
inflammatory effects . 
 
Furthermore, we wanted to determine whether paraben stimulated inflammation in 
fibroblasts is sufficient to stimulate the proliferation of breast cancer cells, which is 
consistent with the impact of an inflamed stroma on carcinogenesis. Conditioned media 
was collected after treating the fibroblasts with parabens and washing the fibroblasts to 
remove any residual intact or hydrolyzed parabens, and used at a 1:1 ratio with the fresh 
media and was applied on autobioluminescent MCF7 cells. From both murine and human 
fibroblasts, paraben-stimulated conditioned media are sufficient to enhance the 
proliferation of MCF7 cells without direct exposure of parabens to the breast cancer cells. 
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At 1 µM, BP and PP, but not MP, significantly induced Il1β mRNA expression in 3T3-L1 
fibroblasts; In contrast, MP and PP, not BP, significantly induced IL1β mRNA expression 
in human BRF cells. As one prominent cytokine in the inflamed stroma, IL1β has been 
shown to increase invasiveness and metastasis of breast tumors and correlates with worse 
prognosis (Brown 2014, Stender, Nwachukwu et al. 2017). Additionally, IL1β is also 
implicated in endocrine and chemotherapy resistance in ER+ breast cancers (Stender, 
Nwachukwu et al. 2017). Whether IL1β in the conditioned media promoted MCF 
proliferation remains to determined.  
 
Upregulation of COX2 leads to the production of prostaglandins, such as PGE2 (Wang and 
Dubois 2006). PGE2 promotes tumor growth by binding to it receptors EP1-4 and 
activating signaling pathways that promote proliferation and inhibit apoptosis, such as Ras-
MAPK pathway and EGFR/PI3K and Akt/ PPAR  pathway (Wang and Dubois 2006). At 
1 µM, all tested paraben significantly induced Cox2 mRNA expression in 3T3-L1 
fibroblasts and BP and PP, but not MP significantly induced COX2 mRNA expression in 
human BRF cells. It remains to be determined whether Cox2/PGE2 underlies the effects of 
the conditioned media collected from paraben-exposed fibroblasts.  
 
Moreover, at 1 µM all tested parabens significantly induced Cyp19a1 mRNA in 3T3-L1 
fibroblasts and MP and BP, but PP, significantly induced CYP19A1 mRNA expression in 
human BRF cells. It remains to be determined whether paraben significantly increases 
estrogen production from exposed fibroblasts thereby increasing ER+ MCF7 cell 
proliferation.  Future studies are needed to determine the nature of the soluble factors that 
drive MCF7 cell proliferation from paraben exposed fibroblasts.  
 
The insight of paraben-induced inflamed fibroblasts enhancing breast cancer proliferation 
is significant as women are exposed to these chemicals on a daily basis at low doses. As 
we only demonstrate the increase of proliferation using a functional assay, additional 
studies are needed to identify the critical soluble factors in the conditioned media from the 
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fibroblasts and the molecular mechanisms by which these soluble factors from paraben-
exposed fibroblasts stimulate breast cancer cell proliferation.  
 
In conclusion, we have shown that parabens, specifically MP, PP, and BP at environmental 
achievable doses, induce the upregulation of IL1β, COX2, and MMP9 in both murine 3T3-
L1 and human BRF cells in vitro. The inflammatory responses induced by parabens are 
accompanied by the activation of NF-κB signaling. Furthermore, we demonstrate that the 
secretions collected from paraben-exposed fibroblasts are sufficient to enhance breast 
cancer proliferation, suggesting that parabens at environmental achievable doses may 
promote inflammation in the stroma thereby promoting breast cancer progression.  
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Figure 3.2. Parabens induce inflammatory gene expression in 3T3-L1 fibroblasts.  
3T3-L1 fibroblasts were treated with selected parabens (0.02, 0.10, 1.0 μM) for the 
indicated time period. DMSO was the vehicle control and LPS was the positive control. 
Relative mRNA expression of inflammatory markers (A. Il1β, B. Mmp9, and C. Cox2) was 
analyzed. The relative mRNA expression was normalized to 36B4 and expressed as fold 
of that of the DMSO sample. Data are mean + SE (n = 3). One-way ANOVA on Ranks 
was performed followed by multiple comparison tests with Student Newman-Keuls 
method to compare with the control. * - p < 0.05, ** - p < 0.01, and *** - p < 0.001. 
62 
  
Figure 3.3. Parabens induce inflammatory gene expression in human BRF 
fibroblasts.  
BRF fibroblasts were treated with selected parabens (0.02, 0.10, 1.0 μM) for the 
indicated time period. DMSO was the vehicle control and LPS was the positive control. 
Relative mRNA expression of inflammatory markers (A. Il1β, B. MMP-9, and C. Cox2) 
was analyzed. The relative mRNA expression was normalized to 36B4 and expressed 
as fold of that of the DMSO sample. Data are mean ± SE (n = 3). One-way ANOVA on 
Ranks was performed followed by multiple comparison tests with Student Newman-







Figure 3.4. Parabens activate NFκB reporter in both murine and human fibroblasts.  
A. 3T3-L1 and B. BRF fibroblasts were infected with adenovirus containing NFκB-Luc 
and β-galactosidase (β-gal) for 15 hours and stimulated with 0.02, 0.1, or 1 μM MP, PP, or 
BP along with appropriate controls for 12 hours. Reporter gene assays were conducted and 
relative luciferase activity was normalized by β-gal for each sample and expressed as fold. 
Data are means + SE (n=3). * P < 0.05, ** P < 0.01, and *** P < 0.001.  
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Figure 3.5. Paraben activates NFκB signaling in murine fibroblasts.  
Fibroblasts were serum starved and treated with vehicle control A. DMSO, B. BP 
(1μM), or C. LPS (5 ng/mL) for indicated times, and whole cell lysate was prepared 
and analyzed by Western analysis with p-p65, p65, IκBα, and β-actin antibodies. 
Relative phosphorylation of p65 was normalized by p65 for each sample and expressed 
as fold. Relative expression of IκBα was normalized by β-actin for each sample and 
expressed as fold. D. IκBα degradation and E. phosphorylation of p65 comparison 
between each treatment with their own time 0. F. BP induced expression of IκBα and 
p-p65 normalized with DMSO. Data are means + SE (n=3). * P < 0.05, ** P < 0.01, 
and *** P < 0.001.  
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Figure 3.6. Paraben activates NFκB signaling in human BRF fibroblasts.  
Fibroblasts were serum starved and treated with A. vehicle control (DMSO), B. MP (1μM), 
and C. LPS (5 ng/mL) for indicated times, and whole cell lysate was prepared and analyzed 
by Western with p-p65, p65, IκBα, and β-actin antibodies. Relative phosphorylation of p65 
was normalized by p65 for each sample and expressed as fold. Relative expression of IκBα 
was normalized by β-actin for each sample and expressed as fold. D. IκBα degradation and 
E. phosphorylation of p65 comparison between each treatment with their own time 0. F. 
MP induced expression of IκBα and p-p65 normalized with DMSO. Data are means + SE 
(n=3). * P < 0.05, ** P < 0.01, and *** P < 0.001.  
A. DMSO 
B. MP (1μM) 
C. LPS 
D. IκBα Degradation 
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Figure 3.7. The conditioned media from paraben-treated fibroblasts promotes breast 
cancer cell proliferation.  
Fibroblasts were serum starved and treated with the negative (-), the vehicle control 
(DMSO), MP (1μM), PP (1μM), BP (1μM), or LPS (5 ng/mL) for 72 hr (A. 3T3-L1 and 
C. BRF) or 10 days (B. 3T3-L1 and D. BRF). CM was collected and incubated with 
autobioluminescent MCF7 cell at a 1:1 ratio with fresh media. Average luminescence was 
measured after 7 days and normalized to the vehicle control and expressed as fold. Data 
are means ± SE (n=6). * P < 0.05, ** P < 0.01, and *** P < 0.001.  
 
B. 3T3-L1 – 10 Day A. 3T3-L1 – 72 Hour 
C. BRF – 72 Hour D. BRF – 10 Day 
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Gene Type Sequence 
36b4 Murine FOR – GCTTCGTGTTCACCAAGGAGGA 
REV – GTCCTAGACCAGTGTTCTGAGC  
36B4 (RPLP0) Human FOR – TGGTCATCCAGCAGGTGTTCGA 
REV - ACAGACACTGGCAACATTGCGG 
Mmp9 Murine FOR – GCTGACTACGATAAGGACGGCA  
REV – TAGTGGTGCAGGCAGAGTAGGA 
MMP9 Human FOR – GCCACTACTGTGCCTTTGAGTC 
REV – CCCTCAGAGAATCGCCAGTACT  
Il1β Murine FOR – TGGACCTTCCAGGATGAGGACA 
REV – GTTCATCTCGGAGCCTGTAGTG  
IL1β Human FOR – CCACAGACCTTCCAGGAGAATG  
REV – GTGCAGTTCAGTGATCGTACAGG  
Cox2  Murine FOR – GCGACATACTCAAGCAGGAGCA 
REV – AGTGGTAACCGCTCAGGTGTTG  
COX2 Human FOR – CGGTGAAACTCTGGCTAGACAG 
REV – GCAAACCGTAGATGCTCAGGGA  
Cyp19a1 Murine FOR – AAGCTCTGACGGGCCCTGGT 
REV – ACGTAGCCCGAGGTGTCGGT  
CYP19A1 Human FOR – CACATCCTCAATACCAGGTCC 
REV – CAGAGATCCAGACTCGCATG  
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CHAPTER 4 : 
PARABENS INDUCE INFLAMMATION IN STROMAL 





Background: Breast stromal inflammation is being identified as a key contributor to breast 
carcinogenesis and breast cancer progression. Understanding the role and contribution of 
each stromal cell type in breast carcinogenesis can lead to novel and effective therapeutic 
or preventative strategies. Parabens are classified as a group of 4-hydroxybenzoic acid 
esters, found ubiquitously in pharmaceuticals, food, personal care products, and industry 
working as anti-microbial agents. Studies have shown that parabens are estrogenic 
endocrine disruptive chemicals in experimental animals and can accumulate in a higher 
amount in the breast cancer samples. Therefore, we hypothesize that parabens may promote 
breast carcinogenesis by negatively modulating breast stromal adipocytes nearby breast 
epithelial cells.  
 
Methods: 3T3-L1 murine and human BRF adipocytes differentiated from respective 
precursor cells were treated with the three most common parabens, methyl-, propyl-, and 
butylparaben (MP, PP, and BP) at environmentally relevant doses (0.02, 0.1, and 1 µM) 
for 6, 12, and 24 h. Gene expression was evaluated by RT-PCR.  The effects of parabens 
on NF-κB activation were studied by NF-κB reporter gene assays in differentiated 3T3-L1 
CARΔ1 cells, which are engineered to express adenovirus receptor to enable adenoviral 
DNA delivery, and by western analysis of p-p65 and IκBα degradation, two critical events 
for NF-κB signaling pathways. Lastly, paraben-treated adipocyte conditioned media was 
studied for their abilities to promote the proliferation of autobioluminescent MCF7 breast 
cancer cells.  
 
Results: A single exposure of BP increases Il1β, Cox2, and Mmp-9 at 6, 12 and 24 h in 
murine adipocytes. A single exposure of MP and BP upregulates MMP-9 in human 
adipocytes. Exposure of MP, PP, and BP downregulates IL1β and COX2 in human 
adipocytes. The NF-κB pathway is activated by parabens shown by the induction of the 
NF-B reporter gene and by increased phosphorylation of p65 and/or degradation of IBα 
in murine adipocytes. In contrast, parabens only induce a modest response in human BRF 
adipocytes. Consistently, the conditioned media from paraben-treated murine adipocytes, 
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but not from human BRF adipocytes, promotes the proliferation of breast cancer MCF7 
cells. 
  
Conclusion: Parabens may play important roles in breast cancer progression by inducing 
inflammation and aromatase expression in the breast stromal adipocytes.   
 
4.2. Introduction 
Breast cancer continues to be the second most common cause of cancer-related death 
among women of various races, despite the improving survival rate due to advances in 
screening and treatment (ACS 2018). Hereditability accounts for less than 10% of breast 
cancer incidences, where the remaining 90% are attributed to modifiable risk factors 
(Darbre 2006, Darbre and Harvey 2014). A few modifiable environmental risk factors are 
obesity, xenoestrogen exposure, alcohol consumption, hormone therapy, and oral 
contraceptives (ACS 2018). The tumor microenvironment or stroma is the collection of 
various cell types, adipocytes, fibroblasts, macrophage, neutrophils, and endothelial cells, 
surrounding tumorigenic epithelial cells that provide a niche conducive to tumor growth. 
The stroma has been found to play a critical role in angiogenesis, proliferation, invasion, 
and metastasis and is greatly affected by these modifiable risk factors (Hanahan 2011).  
 
Obesity, defined by the body mass index (BMI) ≥ 30 kg/m2 and characterized by excess of 
adipose tissue accumulation, is  a critical risk factor linked to breast cancer development, 
recurrence, and decreased survivability (Chan, Vieira et al. 2014, Gathirua-Mwangi, 
Zollinger et al. 2015, Playdon, Bracken et al. 2015). Adipose tissue functions as an 
endocrine organ secreting soluble factors such as cytokines, adipokines, hormones, etc., 
and an obese individual can experience hypertrophy of adipocytes where the volume can 
significantly multiply (Divella, De Luca et al. 2016). As adipocytes reach the limit of fat 
containment, the integrity of the cell membrane becomes comprised and can induce 
hypoxia and necrosis ultimately leading to inflammation (Divella, De Luca et al. 2016). 
Adipocytes can also rupture from excess lipid accumulation, attracting macrophage to 
remove debris further exacerbating inflammation via NF-κB activation (Divella, De Luca 
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et al. 2016, Iyengar, Gucalp et al. 2016). Inflammation within the obese stroma signals the 
release of cytokines, growth factors, and other proteins, thereby promoting changes 
conducive to cancer proliferation, such as mitogenesis, angiogenesis, and ECM remodeling 
(Radisky and Radisky 2007, Iyengar, Gucalp et al. 2016).  
 
As the predominant cell type in breast tissue is the adipocyte, increased adiposity in the 
stroma leads to enhanced estrogen production surrounding breast epithelial cells and raised 
serum estradiol in obese individuals (Howe, Subbaramaiah et al. 2013, Hoy, Balaban et al. 
2017). Moreover, inflammatory cytokines, PGE2, a COX2 product, and adipokines can 
influence the production of estrogen biosynthesis through the induction of aromatase 
(Brown 2014, Iyengar, Gucalp et al. 2016). Aromatase is a cytochrome P450 enzyme 
encoded by the CYP19A1 gene that functions as the rate-limiting step in the conversion of 
androgens to estrogen (Gerard and Brown 2018). Aromatase overexpression and activity 
has been identified in the breast tissue of obese individuals and have a positive association 
with the presence of crown-like structures (CLS), which develop when adipocytes become 
necrotic (Howe, Subbaramaiah et al. 2013, Brown 2014, Gerard and Brown 2018). Taken 
together, this suggests a critical role of stromal inflammation contributes to the obesity-
inflammation-estrogen axis (Gerard and Brown 2018).   
 
It is recognized that environmental exposures particularly EDCs with estrogenic activities 
pose as risk factors for breast cancer development (Cui, Balshaw et al. 2016). EDCs are 
industrial chemicals utilized to enhance product sustainability and extend shelf-life but 
have been identified to dysregulate endocrine systems, causing adverse health outcomes 
(Cui, Balshaw et al. 2016). Parabens are alkyl esters of p-hydroxybenzoic acid incorporated 
into personal care products, pharmaceuticals, food packaging, and paper products for their 
anti-microbial and anti-fungal properties. The most common parabens used in the 
commercial products and therefore often being detected in human biological samples are 
methyl-, propyl-, and butylparaben (MP, PP, and BP) (Giulivo, Lopez de Alda et al. 2016). 
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Parabens have been classified as weak EDCs, however, previous studies have identified at 
low-dose exposures their ability to bind hormone receptors, enhance estrogenicity, and 
promote progression breast cancer (Darbre and Harvey 2014). Moreover, total parabens 
have been detected within normal breast tissue at an average concentration of 85 ng/g of 
tissue with MP and PP in the highest concentrations at 16.6 and 16.8 ng/g tissue 
respectively, indicating the presence of parabens around breast epithelial cells (Barr, 
Metaxas et al. 2012). Furthermore, parabens have been detected in higher amounts in breast 
cancer samples than their normal breast tissue controls, ranging from 17.3 ng/g tissue to 
115 ng/g tissue (Darbre, Aljarrah et al. 2004). Furthermore, parabens have been shown to 
be capable to promote breast epithelial cell growth, however, it is not clear whether 
parabens also negatively affect breast stroma (Darbre and Harvey 2008).   
 
The objective of this study was to determine the effects of common parabens (MP, PP, and 
BP) at environmentally achievable doses (0.02, 0.1, and 1 µM) on mRNA expression of 
inflammatory genes and Cyp19A1 in the stromal adipocytes from murine and human 
origins and the ability of exposed adipocytes to enhance breast cancer cell proliferation. 
We demonstrate that parabens induce the upregulation of inflammatory genes (Il1β and 
Cox2) and ECM remodeling gene Mmp9 and induce activation of the NF-κB pathway. We 
also show paraben-exposed adipocytes conditioned media induces substantial MCF7 
proliferation. 
 
4.3. Materials and Methods 
4.3.1 Reagents 
Methylisobutylxanthine (MIX), dexamethasone (DEX) and insulin (Ins) were purchased 
from Sigma Aldrich (St Louis, MO). Dimethyl sulfoxide (DMSO); methyl-, propyl-, and 
butylparaben were from Acros Organics (>99%, Thermo Fisher Scientific, Pittsburg, PA). 
Ultra-pure lipopolysaccharide (LPS) was from List Biological Laboratories (Campbell, 
CA). Phospho-NF-κB p65 (Ser536) (no. 3033) and NF-κB -p65 (D14E12) XP (no. 8242) 
were purchased from Cell Signaling Technology. IκBα (C-21): sc-371 was purchased from 
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Santa Cruz Biotechnology. Anti-β-actin (AC-15) (no. A1978) was from Sigma-Aldrich. 
Neomycin (G-418) was purchased from Research Products International (Mount Prospect, 
IL) 
 
4.3.2. Cell Culture  
Murine 3T3-L1 fibroblasts (ATCC, Manassas, VA) were grown in Dulbecco’s Modified 
Eagles medium (DMEM) containing 10% calf serum (HyClone).  Murine 3T3-L1 
expressing coxsackievirus and adenovirus receptor (CARΔ1) cells were donated by Dr. 
Orlicky (Orlicky DJ 2001) and were grown in DMEM containing 10% fetal bovine serum 
(FBS) (Atlanta Biological, Flowery Branch, GA).  Human subcutaneous breast fat 
preadipocytes (BRF) (Zenbio, NC) were grown in Preadipocyte Medium (PM-1) according 
to the manufacturer’s instructions (Zenbio, NC). Human Autobioluminescent MCF7 cell 
line was a gift from Dr. Ripp (490 BioTech, Inc., Knoxville, TN) (Xu, Ripp et al. 2014) 
and was grown in DMEM containing 10% FBS with G-418. All were grown in 5% CO2, 
37oC conditions. 
 
4.3.3. Immortalization of Primary BRF Cells 
Immortalization of primary BRF cells was completed by infecting the BRF cells with 
lentivirus encoding the SV40LT antigen. SV40LT antigen was cloned into a lentiviral 
vector carrying the neomycin phosphotransferase gene (Alwin Prem Anand, Gowri Sankar 
et al. 2012). Lentivirus particles were generated by co-transfecting SV40LT vector with 
packaging (psPAX2) and envelope (pMD2.G) vectors (Addgene; Boston, MA) in 
HEK293Ta cells (GeneCopoeia, Inc; Rockville, MD) using FuGENE® HD transfection 
reagent (Promega Corporation; Madison, WI) following manufacturer’s guidelines. Once 
developed, the lentivirus particles were used to infect the BRF cells. Stable cell lines were 
selected using G418 antibiotic (300 µg/ml) for two weeks. 
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4.3.4. Adipocyte Differentiation 
3T3-L1 fibroblasts were grown to confluency, and on the day of confluency cells were 
treated with DMEM containing 10% FBS, 0.5mM MIX, 10μg/mL Ins, and 1μM of DEX 
for 3 days (day 0-3). The cells were then grown in DMEM containing 10% FBS and 
10μg/mL Ins for 2 days (day 4-5). Lastly, the cells are maintained in their differentiated 
state with DMEM containing 10% FBS (day 6-7). BRF fibroblasts were grown to 
confluency, on the day of confluency cells were treated with Adipocyte Differentiation 
Media (DM-2) (Zenbio, NC) for 7 days. After 7 days, DM-2 was removed and Adipocyte 
Maintenance Media (AM-1) (Zenbio, NC) was added for an additional 7 days.   
 
4.3.5. Oil red O Staining and Quantification 
Lipid accumulation after differentiation of adipocytes was stained with oil red O (ORO) as 
previously described (Hu, Chen et al. 2013).  
 
4.3.6. Paraben Treatment 
To detect the inflammatory effects of low-dose paraben on 3T3-L1 or BRF fibroblasts, a 
single exposure  of 0.02, 0.10, or 1.0 μM methyl-, propyl-, or butylparaben was 
administered in low-serum conditions, 0.25% calf serum (HyClone) for 3T3-L1 cells and 
1% charcoal-stripped fetal bovine serum (CS-FBS) (HyClone) for BRF cells.  DMSO and 
LPS were used as vehicle control and positive control, respectively. 
 
4.3.7. RNA and Quantitative Real-Time PCR  
Total RNA was prepared from adipocytes using TRIzol (Invitrogen Coorporation, 
Carlsbad, CA) following the manufacturer’s protocol. NanoDrop ND-1000 
Spectrophotometer (NanoDrop Technologies, Wilmington, DE) was utilized to measure 
total RNA. Reverse transcription was completed with the High-Capacity cDNA Reverse 
Transcription kit (Thermo Fisher Scientific) following the manufacturer’s protocol. mRNA 
expression of adipocyte inflammation markers and housekeeping gene 36B4 (Table S1) 
were analyzed quantitatively using PowerUp SYBR Green Master Mix (Thermo Fisher 
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Scientific) in a 96-well PCR plates with an ABI 7900HT Real-Time PCR System with 
cycle conditions of 50oC 2 min, 95 oC 2 min, and 40 cycles of 95oC for 15s/60oC for 1 min. 
The relative gene expression was calculated utilizing 2(-ΔΔCt) method and normalized with 
36B4. 
 
4.3.8. Reporter Gene Assays 
3T3-L1 CARΔ1 were seeded in a 24-well plate format and infected with adenovirus 
encoding NF-κB-Luc reporter gene and adenovirus encoding β-galactosidase (β-gal) 
control plasmid for 15 h, as described previously (Purohit, Hu et al. 2013). After infection, 
the cells were differentiated following the 3T3-L1 protocol. The cells were probed with 
various parabens for 6 and 12 h. The cell lysate was prepared utilizing Reporter Lysis 5X 
Buffer (Promega). Reporter luciferase activity was analyzed using GloMax Luminometer 
(Promega, Madison, WI) and normalized by β-gal activities. 
 
4.3.9. Western Blot Analysis 
Total cell lysates of adipocytes were prepared, centrifuged, and protein concentrations 
measured by Pierce BCA protein assay kit (Thermo Fisher Scientific). 20-40 μg of total 
cell lysate were run through a polyacrylamide gel and transferred to polyvinylidene 
difluoride membrane (Bio-Rad). The membrane was blocked in 20 mM Tris-HCl, 137 mM 
NaCl, and 0.1% Tween 20 (pH 7.4) containing 5% nonfat milk or 5% bovine serum 
albumin (BSA). The membrane was immunoblotted with primary antibodies at 4  oC 
overnight followed by secondary antibody conjugated with horseradish peroxidase. The 
signal was detected utilizing SuperSignal West Pico PLUS Chemiluminescent Substrate 
(Thermo Scientific), HyBlot CL autoradiography film (Denville Scientific), and a Konica 




4.3.10. Conditioned Media Collection 
3T3-L1 and BRF fibroblasts were seeded into 60 mm dishes and probed to differentiate 
following their respective protocols. Each plate of cells was treated with MP, PP, BP (each 
at 1 µM) or controls (DMSO or LPS) in 5% CS-FBS. After 72 h or 10 days, the treatment 
was removed, and the cells were washed twice with phenol-red free (PRF) media 
(HyClone). To collect the conditioned media (CM), cells were cultured for 48 h in PRF 
media with 5% CS-FBS, penicillin, and streptomycin. After 48 h, the media was collected 
and centrifuged at 600 rpm for 5 minutes. The supernatant was transferred into a fresh tube 
and stored at 4oC before use.  
 
4.3.11. Bioluminescent imaging  
Autobioluminescent MCF7 cells were plated at 30% confluency in duplicate wells of 24-
well opaque, clear bottom plates (Labnet/Corning Inc., Cary, NC). After attachment 
overnight, MCF7 cells were washed with PRF media and treated with CM: 5% CS-FBS 
PRF media in a 1:1 ratio. Treatment persisted for 7 days with changing CM at day 4. On 
day 7, plates were imaged utilizing a CCD-based IVIS Lumina imaging system 
(PerkinElmer). Autobioluminescent readings were acquired 3 times at 10 min intervals 
according to the manufacturer’s instructions. 
 
4.3.12. Statistical Analysis 
All data are presented as means + SE. Measurements were performed in triplicates unless 
otherwise indicated. Statistical analysis was performed using SigmaPlot 14.0 (Systat 
Software). One-way ANOVA on ranks or one-way ANOVA with repeated measures 
followed by multiple comparison tests (Student-Newman-Keuls method) were used to 
determine the differences among treatment groups or time points. Student’s t-tests were 
conducted to evaluate LPS compared to the control. The level of significance was set at P 
< 0.05. The effects of treatment and plate location on fold change of average radiance were 
analyzed using two-way ANOVA analysis for each time point in 3T3-L1 and human BRF 
adipocytes.Post hoc multiple comparisons were performed with Tukey’s adjustment. 
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Statistical significance was identified at the level of 0.05. Analyses were conducted in SAS 
9.4 TS1M4 for Windows 64x (SAS institute Inc., Cary, NC). 
 
4.4. Results 
4.4.1. Parabens Induce mRNA Expression of inflammatory genes and CYP19a1 in 
Murine 3T3-L1 Adipocytes and Human BRF Adipocytes 
3T3-L1 fibroblasts were first differentiated following the 7-day differentiation protocol 
(Figure 4.1.A.) and then exposed to MP, PP, or BP or their vehicle control at 0.02, 0.1, or 
1 µM for 6, 12, or 24 h.  LPS was included as a positive control.  Typically, there is ~100% 
and ~50% differentiation of 3T3-L1 and BRF cells, respectively (Figure 4.1.A-B). The 
inflammatory response to parabens differs depending on the length of the side chain, dose, 
and time of exposure. Propylparaben and BP significantly upregulated inflammatory Il1β 
mRNA expression in 3T3-L1 adipocytes. Compared to the vehicle control (DMSO), PP 
increased maximally ~ 7 fold of Il1β mRNA expression at 1 µM at 12 h (p<0.001), but was 
not sustained at 24 h (p<0.001) of exposure. BP at all tested doses significantly increased 
Il1β mRNA expression at 6, 12, and 24 h of exposure. At 1 µM BP increased the maximal 
~ 17 fold of Il1β mRNA expression at 6 h (p<0.01) and ~ 3 fold (p<0.05) and ~ 4.5 fold 
(p<0.001) at 12 and 24 h, respectively (Figure 4.2.A). In contrast, MP did not influence 
Il1β mRNA expression at 6 or 12 h but downregulated it at 24 h (Figure 4.2.A). A maximal 
2 fold Il1β mRNA level was induced by LPS at 24h of exposure (Figure 4.2.A). 
 
In addition to Il1β, we also examined Mmp9 mRNA expression, a key MMP in matrix 
remodeling in breast cancer growth. Even though LPS significantly upregulated ~ 3.5 fold 
of Mmp9 mRNA expression at 6 h (p<0.001), reaching ~ 8 fold at 12 h (p<0.001), and ~ 
3.5 fold at 24 h exposure, there was not  much effects by parabens except that PP increased 
3 fold at 12 h at 1 µM (p<0.001) and BP increased 2.5 fold at 6 h at 1 µM (p<0.001) and 
2.5 fold at 12 h at 0.02 µM (p<0.01) compared to DMSO (Figure 4.2.B). We examined the 
effects of parabens on Cox2 mRNA expression in adipocytes as COX2 upregulation is 
greatly associated with progression of many cancers, including breast cancer (Denkert, 
Winzer et al. 2004, Sano, Kogashiwa et al. 2018). Propylparaben and BP significantly 
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upregulated Cox2 mRNA expression at 6, 12, and 24 h (p<0.05). Propylparaben induced ~ 
2.5 fold of Cox2 mRNA expression at 6 h at 1 µM, which has remained at 12 h but subsided 
at 24 h. All tested doses of BP induced significant Cox2 mRNA at 6 h and 24 h, with a 
maximal 4.5 fold at 1 µM (p<0.001) compared to the control. In contrast, LPS only 
increased 2 fold of Cox2 mRNA expression at 6 h (p<0.05) (Figure 4.2.C).  
 
Lastly, we analyzed mRNA expression of Cyp19a1, the enzyme responsible for the 
conversion of androstenedione and estrone to estrogen (Gerard and Brown 2018). Parabens 
tested, PP and BP in particular, significantly upregulated Cyp19a1 mRNA expression. PP 
at all tested concentrations significantly upregulated Cyp19a1 mRNA expression at both 6 
and 12 h (p<0.001). PP at 1µM induced ~ 4 fold of Cyp19a1 mRNA expression at 6 h, 
which was increased to ~ 6 fold at 12 h and subsided to the basal level at 24 h.  BP at all 
tested concentrations significantly upregulated Cyp19a1 mRNA expression at 6, 12, and 
24 h. Butylparaben at 1 µM induced a maximal 10 fold of Cyp1a mRNA expression at 6 h 
(p<0.001), which was decreased to 3.5 fold at 12 and 24 h (p<0.05) compared to the vehicle 
control. In contrast, LPS only increased ~ 2 fold of Cyp19a1 mRNA expression at 24 h 
exposure (p<0.001) (Figure 4.2.D). 
 
Similar to those of murine adipocytes, all three parabens also induced differential responses 
in the human BRF adipocytes, depending on the length of the side chain, dose, and time of 
exposure (Figure 4.3.).  Butylparaben induced maximal ~ 3 fold of IL1β mRNA expression 
at 12 h at 0.1 µM but downregulated it at 6 and 24 h at all tested in human concentrations 
in the BRF adipocytes (Figure 4.3.A). Methylparaben and PP both downregulated IL1β 
mRNA expression at 6 h while MP and PP had minimal effect at 12 and 24 h (Figure 
4.3.A). In contrast, LPS induced a maximal 2.5 fold of IL1β mRNA expression at 12 h and 
had minimal effects at 6 and 24 h (Figure 4.3.A).  
 
In contrast, all three parabens induced more robust responses of MMP9 in human BRF 
cells. Compared to the controls, BP induced ~ 2 fold of MMP9 mRNA expression at 6 h 
and ~ 3.5 fold at 24 h at 1 µM. MP induced ~ 4 fold of MMP9 mRNA at 0.1 µM (p<0.01) 
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and ~ 4.5 fold  at 1 µM (p<0.05) only at 24 h (p<0.05) (Figure 4.3.B). PP had no significant 
induction of MMP9 mRNA expression. LPS induced ~ 2.5 fold of MMP9 mRNA 
expression at 6 h in human BRF cells (Figure 4.3.B). All three parabens downregulate 
COX2 mRNA expression at 6 and 12 h with no significant changes at 24 h (Figure 4.3.C).  
 
Lastly, CYP19A1 mRNA expression was significantly downregulated by all three tested 
parabens at 6 h with no significant response at 12 or 24 h except BP at 0.02 µM at 12 h of 
exposure, which increased CYP1A1 to ~ 1.3 fold compared to the vehicle control (p<0.05). 
Propylparaben also significantly upregulates CYP19A1 mRNA expression by 1.5 fold at 
0.02 µM at 24 h (p<0.01). Similarly, LPS does not induced an increase of CYP19A1 mRNA 
expression at 6, 12, or 24 h in human BRF adipocytes (Figure 4.3.D).  
 
4.4.2. Parabens Regulate NF-κB Signaling in Murine and Human Derived Adipocytes 
Next, we investigated the effects of paraben on the NF-κB signaling pathway, which is 
critical signaling that drives inflammatory gene expression. First, we investigated NF-κB 
activation using NF-κB-responsive luciferase reporter assays.  We validated the infection 
efficiency of adenovirus-mediated infection in differentiated 3T3-L1 CARΔ1 adipocytes 
using adenoviral GFP (Figure 4.4.A).  Then 3T3-L1 CARΔ1 fibroblasts were infected with 
adenovirus encoding an NF-κB-Luc receptor and then differentiated. At 6 h, MP activated 
NF-κB in 3T3-L1 CARΔ1 adipocytes only at 0.02 µM (p<0.05).  LPS induced ~ 3 fold of 
activation at 6 h, which was attenuated by an NF-κB inhibitor CAPE (Figure 4.4.B). 
Similar to the gene expression results, PP induced a modest but significant NF-κB 
activation in 3T3-L1 adipocytes only at 1 µM and at 12 h (p<0.05). (Figure 4.3.C). 
Butylparaben induced ~ 1.5 fold of activation only at 0.02 µM and at 12 h (p<0.05). In 
contrast, LPS induced 4 fold of NF-κB activation in 3T3-L1 adipocytes at 12 h. 
 
We further confirmed paraben-induced NF-κB activation in 3T3-L1 cells by analyzing the 
phosphorylation of p65 and degradation of IκBα, two key events leading to NF-κB 
activation (Figure 4.5.A). Quantification of densitometry showed that compared to the 
respective vehicle control (DMSO), BP at 1 μM induced the degradation of IκBα beginning 
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at 30 min (p<0.001) (Figure 4.5.D) and phosphorylation of p65 also at 30 min (p<0.05) 
(Figure 4.5.E). LPS also showed significant degradation of IκBα and phosphorylation of 
p65 beginning at 5 min (p<0.001). When MP NF-κB activation was normalized by DMSO, 
IκBα degradation had a minimal response, however p65 phosphorylation was significantly 
enhanced demonstrating the bimodal activation at 5 and 30 minutes (Figure 4.5.F). NF-κB 
activation by BRF cells was not tested as gene expression analysis showed a decrease in 
inflammatory mRNA markers.  
 
4.4.3. Conditioned Media from Parabens-Treated Adipocytes Regulates Breast Cancer 
Cell Proliferation 
To explore the effects of paraben exposure on stromal induction and cancer progression, 
we evaluated the effects of the CM collected from paraben-treated adipocytes on the 
proliferation of human breast cancer cells MCF7. We evaluated CM collected after short-
term (72 h) and long-term (10 days) exposure of parabens on both 3T3-L1 and BRF 
adipocytes. The CM was then used to induce the proliferation of autobioluminescent MCF7 
cells. At 72 h, PP induced greater proliferation of MCF7 cells compared to those of other 
parabens, but it did not reach statistical significance. Moreover, paraben stimulated 
proliferation is not significantly greater than the vehicle control (DMSO) (Figure 4.6.A). 
In contrast, the CM collected from BP, but not MP or PP-treated 3T3-L1 adipocytes for 10 
days induced significant proliferation of autobioluminescent MCF7 cells compared to the 
vehicle control (p<0.05) (Figure 4.6.B). Interestingly, the CM from both MP and BP 
exposed human BRF adipocytes appeared to suppress the proliferation of MCF7 cells at 
72 h (p<0.001), whereas the CM from PP exposed BRF adipocytes had no effects compared 
to the vehicle control at 72 h (Figure 4.6.C). Lastly, MCF7 cell proliferation is diminished 
upon treatment with the CM from MP, PP, and BP exposed adipocytes for 10 days 
(p<0.001), confirming downregulated gene expression results (Figure 4.6.D).  
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4.5. Discussion and Conclusion 
To our knowledge, our study is the first to demonstrate the effect of parabens at 
environmental achievable doses influence mRNA expression of inflammatory genes and 
aromatase, CYP19A1, in murine and human adipocytes differentiated from human breast 
stromal cells. Using conditioned media, we determined the effect of secretion from low-
dose parabens exposed adipocytes on breast cancer cell growth. Our results demonstrate 
that typical exposure to parabens within the environment induce a pro-inflammatory 
response and upregulate aromatase Cyp19a1 in murine adipocytes. In contrast, parabens 
were found to be protective against inflammation by downregulation of pro-inflammatory 
genes and CYP19A1 in human BRF adipocytes. Consistently, the conditioned media from 
paraben-exposed murine adipocytes, but not from human BRF adipocytes, promotes breast 
cancer cell proliferation. 
 
Parabens are preservatives utilized in industry including personal care products, 
pharmaceuticals, food, etc. causing a daily ubiquitous presence in the environment (Darbre 
and Harvey 2008, Darbre and Harvey 2014). These chemicals found in creams and lotions 
are absorbed dermally while absorption through the gastrointestinal (GI) tract is another 
avenue, particularly for food and pharmaceutical products. Esterases in the skin and in the 
GI tract hydrolyze parabens quickly, however intact parabens are detected in the blood, 
breast milk, placenta, and urine (Sandanger, Huber et al. 2011, Zhao, Liu et al. 2014, 
Kolatorova 2017, Shen, Liang et al. 2017). Within 5 h unconjugated parabens are present 
at low levels in human serum, at 12 h hydrolyzed metabolites are no longer present in 
serum, and by 24 h conjugated parabens are the all that remain (Shin, Shin et al. 2019). All 
paraben and metabolites are excreted by 72 h after a single exposure (Shin, Shin et al. 
2019).  
 
Parabens influence a variety of endocrine-related diseases including obesity as obesogens 
and reproductive diseases in both men and women (Hu, Chen et al. 2013, Kirchhof and de 
Gannes 2013, Hu, Kennedy et al. 2016, Guerra, Sanabria et al. 2017). Some of these 
diseases are related to the estrogenic nature of parabens, however, they do influence other 
82 
endocrine pathways. Parabens have been identified to promote breast cancer cell 
proliferation, invasion, and metastasis possible through modulation of estrogen receptor, 
human epidermal growth factor receptor, androgen receptor, G protein-coupled estrogen 
receptor 1. (Darbre and Harvey 2014, Lillo, Nichols et al. 2017).  
 
A breast cancer tumor requires the cooperation of the surrounding stromal cells to create a 
niche that provides the perfect environment for growth and proliferation (Hanahan 2011). 
The stroma is a complex network of fibroblasts, adipocytes, immune cells, endothelial 
cells, macrophages, etc. all communicating with each other and adjacent epithelial cells 
(Bussard, Mutkus et al. 2016). Stromal adipocytes are the most abundant in the obese breast 
and function as the estrogen source for postmenopausal women. Adipocytes are endocrine 
organs, capable of secreting adipokines, pro-inflammatory cytokines, chemokines, 
estrogen, and other factors, which then influence surround breast epithelial cells through 
cross-talk. Adipocytes can be trained to support and enable tumor growth and therapy 
resistance through local inflammation (Majidinia and Yousefi 2017). In addition to the 
ability to store energy in the form of lipids, adipocytes release glycerol and fatty acids into 
the stroma, which are necessary for the synthesis of epithelial cell membranes and 
metabolic components (Hoy, Balaban et al. 2017). Adipocytes found in a cancerous 
microenvironment have increased expression of matrix metalloproteinases (MMPs) and 
pro-inflammatory cytokines, including interleukin (IL1β) and cyclooxygenase (COX2) 
(Bussard, Mutkus et al. 2016, Divella, De Luca et al. 2016, Iyengar, Gucalp et al. 2016). 
Our findings add to the established literature by demonstrating parabens' abilities to induce 
inflammation and ECM remodeling gene in murine adipocytes, creating a conducive 
environment promoting breast cancer cell growth.  
 
In this study, we have aspired to address the effects of common, household parabens at 
environmentally achievable doses on stromal adipocytes and the subsequent effect of 
exposed adipocytes on breast cancer cell proliferation. Our results demonstrate that 
parabens at low concentrations upregulate mRNA for Cox2, Il1β, and Cyp19a1 in murine 
adipocytes and upregulate MMP9 in human adipocytes in type, dose, and exposure time-
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dependent manner. In murine adipocytes, parabens elicited an inflammatory response with 
the increasing length of the alkyl side-chain (MP < PP < BP), where BP most often induced 
the most significant response over time. 
 
The increased inflammatory mRNA expression in murine adipocytes is confirmed by the 
activation of NF-κB reporter and the signaling events of phosphorylation of p65 and IBα 
degradation. Additionally, the timing of activation of NF-κB reporter mimics the gene 
expression in that MP induces a response in a shorter period of time compared to that of 
PP or BP. Although we demonstrate parallel effects of NF-B activation with inflammatory 
gene Il-1β and Cox-2 by parabens, whether inflammatory effects induced by parabens in 
adipocytes are mediated by NF-B pathway need to be confirmed in the future. We did not 
identified that parabens directly activate NF-B pathway, but they likely activate other 
signaling pathways that network with NF-B leading to activation. More studies are 
necessary to elucidate the exact signaling mechanisms activated in stromal adipocytes upon 
paraben treatment, especially considering parabens ability to bind and activate multiple 
hormone and protein receptors. 
 
In contrast, parabens induced a modest response of inflammatory genes and CYP19A1 in 
human adipocytes, demonstrating a species-specific response to parabens in the stromal 
adipocytes. A single exposure of MP and BP only provokes a higher and sustainable MMP9 
mRNA expression in the human BRF adipocytes, suggesting that these human adipocytes 
may be more influential in ECM remodeling than inflammation. Interestingly, the 
downregulation of inflammatory gene expression upon paraben treatment suggests a 
protective effect in human adipocytes.  
 
Furthermore, we aimed to determine the effect of paraben-stimulated adipocytes can 
stimulate the proliferation of breast cancer cells. Conditioned media was acquired after 
treating adipocytes with parabens and washing to remove any residual intact or hydrolyzed 
parabens. The CM was used in a 1:1 ratio with fresh media to support the growth of 
autobioluminescent MCF7 cells. The CM collected 72 h from the paraben-exposed murine 
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adipocytes did not stimulate the proliferation of MCF7 cells, but the CM collected 10 days 
from BP-exposed adipocytes was sufficient to enhance MCF cell proliferation. The finding 
of secretion from inflamed adipocytes inducing proliferation of breast cancer cells agrees 
with the understood effects of inflammation in the stroma on breast cancer (Howe, 
Subbaramaiah et al. 2013, Gerard and Brown 2018). Interestingly, the CM collected from 
paraben-exposed human adipocytes showed decreased proliferation of MCF7 cells, which 
is consistent with the suppression of IL1β, COX2 and CYP19A1 mRNA expression by 
parabens, suggesting that parabens could be protective in these human adipocytes.  
 
Previous studies have indicated that body fatness is protective against breast cancer in 
premenopausal women and deleterious in postmenopausal women (Amadou, Ferrari et al. 
2013, Nichols, Schoemaker et al. 2017). Therefore, a future study comparing the effects of 
CM collected from both pre- and postmenopausal stromal adipocytes with known BMI on 
breast cancer cell proliferation could elucidate these results. Additional studies to solidify 
results such as identifying the soluble factors within the CM from the adipocytes and the 
molecular mechanisms activated from paraben-exposed adipocytes are also necessary.  
 
In conclusion, we have shown that parabens, common preservatives in household products, 
at environmentally achievable doses promote mRNA expression of pro-inflammatory 
genes and Cyp19a1 in 3T3-L1 adipocytes. The inflammatory response of upregulated Il1β 
and Cox2 expression induced by parabens are consistent with NF-κB activation. In 
contrast, parabens only induce a modest response in human BRF adipocytes. Further 
studies are needed to study the effects of long term with repeated exposure of parabens in 
adipocytes and to confirm the stromal response to parabens in vivo to further define the 
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  A. 3T3-L1 
B. BRF 
Figure 4.1. Adipocyte differentiation of 3T3-L1 and the human BRF cells.   
The cell images demonstrating 3T3-L1 (A) and BRF fibroblasts (B) differentiation into 
adipocytes and lipid accumulation (stained by ORO lipophilic stain) following standard 








Figure 4.2. Parabens induce mRNA expression of inflammatory genes and Cyp19a1 
in 3T3-L1 adipocytes.  
3T3-L1 adipocytes were treated with selected parabens (0.02, 0.10, 1.0μM) for the 
indicated time period. DMSO was the vehicle control and LPS was the positive control. 
Relative mRNA expression of inflammatory markers (A. Il1β, B. Mmp9, C. Cox2, and D. 
Cyp19a1) was analyzed. The relative mRNA expression was normalized to 36B4 and 
expressed as fold of that of the DMSO sample. Data are mean + SE (n = 3). One-way 
ANOVA on Ranks was performed followed by multiple comparison tests with Student 





Figure 4.3. Parabens induce mRNA expression of inflammatory genes and CYP19A1 
in human BRF adipocytes.  
BRF adipocytes were treated with selected parabens (0.02, 0.10, 1.0μM) for the indicated 
time period. DMSO was the vehicle control and LPS was the positive control. Relative 
mRNA expression of inflammatory markers (A. IL1β, B. MMP9, C. COX2, and D. 
CYP19A1) was analyzed. The relative mRNA expression was normalized to 36B4 and 
expressed as fold of that of the DMSO sample. Data are mean + SE (n = 3). One-way 
ANOVA on Ranks was performed followed by multiple comparison tests with Student 
Newman-Keuls method to compare with the control. * - p < 0.05, ** - p < 0.01, and *** - 







Figure 4.4. Parabens activate NFκB reporter in murine adipocytes.  
3T3-L1 CARΔ1 fibroblasts were infected with adenovirus containing NFκB-Luc and 
β-galactosidase (β-gal) for 15 h and then differentiated following 3T3-L1 differentiation 
protocol. A. GFP luminescence verifying infection of adenovirus into 3T3-L1 CARΔ1 
adipocytes. Adipocytes were stimulated with 0.02, 0.1, or 1 μM MP, PP, or BP along 
with DMSO and 5 ng/mL LPS as controls for B. 6 h and C. 12 h. Reporter gene assays 
were conducted and relative luciferase activity was normalized by β-gal for each sample 
and expressed as fold. Data are means ± SE (n=3). * P < 0.05, ** P < 0.01, and *** P < 
0.001. 
B. 6 Hours 
 






Figure 4.5. Paraben activates NFκB signaling in murine adipocytes.  
Adipocytes were serum starved and treated with vehicle control A. DMSO, B. BP 
(1μM), or C. LPS (5 ng/mL) for indicated times, and whole cell lysate was prepared 
and analyzed by Western analysis with p-p65, p65, IκBα, and β-actin antibodies. 
Relative phosphorylation of p65 was normalized by p65 for each sample and expressed 
as fold. Relative expression of IκBα was normalized by β-actin for each sample and 
expressed as fold. D. IκBα degradation and E. phosphorylation of p65 comparison 
between each treatment with their own time 0. F. BP induced expression of IκBα and 
p-p65 normalized with DMSO. Data are means + SE (n=3). * P < 0.05, ** P < 0.01, and 
*** P < 0.001. 
 
Figure 6. Paraben activates NFκB signaling in murine adipocytes. Adipocytes were 
serum starved and treated with vehicle control A. DMSO, B. BP (1μM), or C. LPS (5 
ng/mL) for indicated times, and whole cell lysate was prepared and analyzed by Western 
analysis with p-p65, p65, IκBα, and β-actin antibodies. Relative phosphorylation of p65 
was normalized by p65 for each sample and expressed as fold. Relative expression of 
IκBα was normalized by β-actin for each sample and expressed as fold. D. IκBα 
degradation and E. phosphorylation of p65 comparison between BP (1μM) and controls. 
Data are means + SE (n=3). * P < 0.05, ** P < 0.01, and *** P < 0.001.  
A. DMSO 
B. BP (1μM) 
C. LPS 
D. IκBα Degradation 
E. p65 Phosphorylation 




Figure 4.6. The conditioned media from paraben-treated adipocytes promotes 
breast cancer cell proliferation. 
 Adipocytes were serum starved and treated with the negative (-), vehicle control 
(DMSO), MP (1μM), PP (1μM), BP (1μM), or LPS (5 ng/mL) for 72 h (A. 3T3-L1 and 
C. BRF) and 10 days (B. 3T3-L1 and D. BRF). CM was collected and incubated with 
autobioluminescent MCF7 cell at a 1:1 ratio with fresh media. Average radiance was 
measured after 7 days and normalized to the vehicle control and expressed as fold. Data 
are means ± SE (n=6). * P < 0.05, ** P < 0.01, and *** P < 0.001.  
B. 3T3-L1 – 10 Day A. 3T3-L1 – 72 Hour 
C. BRF – 72 Hour D. BRF – 10 Day 
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CHAPTER 5 : 






This dissertation contains two primary experiments detailed in Chapters 3 and 4. Chapter 
3 details the inflammatory effect of MP, PP, and BP at environmentally achievable doses 
on fibroblasts. Low-dose (i.e., 0.2–1 µM) paraben exposure led to the upregulation of 
inflammatory mRNA expression including Il1β and Cox2 in both murine 3T3-L1 and 
human BRF fibroblasts. MMP9 mRNA expression was also upregulated by parabens in 
murine cells but more significantly in human fibroblasts. These results demonstrate the 
ability for a single exposure of parabens to fibroblasts to influences inflammatory and 
matrix remodeling gene expression patterns. Additionally, parabens increased the mRNA 
expression of Cyp19A1 or aromatase implicating parabens’ ability to increase estrogen 
production. Activation of the NF-κB signaling pathway was confirmed by reporter gene 
and western blot analysis, consistent with an inflammatory gene response. The wavering 
trends of IκBα degradation and p65 phosphorylation could be due to paraben’s ability to 
activate a variety of different signaling pathways that ultimately result in influencing NF-
κB. The CM of the paraben treated fibroblasts enhanced proliferation of MCF7 breast 
epithelial cells compared to their vehicle control. Therefore, parabens at low-doses are able 
to stimulate inflammation in stromal fibroblasts, which in turn are able to promote the 
proliferation of breast cancer cells.  
 
Chapter 4 addresses the inflammatory effect of MP, PP, and BP on stromal adipocytes. 
Paraben exposures led to an upregulation of inflammatory Il1β, Mmp9, and Cox2 in murine 
adipocytes, but surprisingly decreased Il1β and Cox2 mRNA expression in the human 
adipocytes. Moreover, both 3T3-L1 and BRF adipocytes induced the upregulation of 
Cyp19a1 or aromatase upon paraben treatment. Parabens activated the NF-κB pathway as 
indicated by the reporter gene and western blot analysis in 3T3-L1 adipocytes. Similar to 
the fibroblasts, more detailed analysis of the upstream activation of NF-κB could aid in 
understanding the variance in inflammatory gene expression and NF-κB patterns. 
Consistently, long-term (10 days) exposure of parabens to differentiated 3T3-L1 
adipocytes led to CM that enhanced MCF7 cell proliferation. However, paraben exposed 
human adipocytes suppressed MCF7 cell proliferation compared to vehicle control 
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(DMSO) similar to gene expression, demonstrating a species-specific response of 
adipocytes to paraben exposure.  
 
In summary, both murine and human stromal fibroblasts and adipocytes showed response 
when exposed to environmentally relevant doses of paraben. Murine fibroblasts and 
adipocytes activate inflammatory signaling pathways and upregulating cytokines that are 
closely associated with breast cancer progression. Murine fibroblasts and adipocytes have 
consistent upregulation of inflammatory mRNA expression as well as NF-κB activation 
and MCF7 growth promotion. Even though human fibroblasts follow suit with murine 
cells, human adipocytes appear to have an alternate effect leading to protection against 
inflammation.  
 
5.2. Significance of the Study 
Breast cancer is a complex disease that affects women globally. As improvements are being 
made with treatment causing a decline in death rates, women are still being diagnosed with 
invasive breast cancer at rates similar to previous decades. With the stroma play a critical 
role in breast cancer, understanding the contribution from each cell type is necessary to 
identify potential prevention or treatment strategies. In breast cancer microenvironment, 
fibroblasts and adipocytes are the two most common stromal cells.  
 
The study of the negative effects of environmental chemical exposure on breast cancer via 
a stromal inflammation can give new insight into addressing breast cancer from a different 
perspective. As parabens, a commonly used anti-microbial found in personal care products, 
food, pharmaceuticals, and more, have the ability to induce inflammation in stromal cells, 
the local inflammation surround breast epithelial cells is enhanced. Inflammation functions 
as a promoter to cancer progression in that it stimulates the opening of DNA strands, 
increasing vulnerability to mutations. As human are exposed to fresh parabens multiple 
times a day, unconjugated parabens found in serum stimulate inflammation in stromal cells 
continuously leading to an inflamed microenvironment. If there are abnormal epithelial 
cells already present in the stroma (e.g., DCIS), this paraben-induced inflammation can 
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lead to the promotion of breast cancer. Therefore, this study indicates that parabens at daily 
human exposure levels can induce stromal inflammation, which is then to enhance breast 
cancer progression.  
 
When addressing obesity and breast cancer, aromatase is often thought of to be the link 
bringing the two together. Aromatase functions in the conversion of estrogens to estradiol, 
and greater levels of estradiol contacting ER+ breast cancers can obviously stimulate 
proliferation. Parabens are shown to increase the expression of aromatase in fibroblasts and 
adipocytes. Assuming the increase in aromatase leads to increased estrogen secretion into 
the conditioned media, both fibroblasts and adipocytes can be influence the amount of 
estrogen present in the microenvironment ultimately leading to breast cancer progression 
in ER+ breast cancers.  
 
Therefore, this study demonstrates how parabens have the potential to enhance breast 
cancer proliferation solely from parabens’ effect on stromal cells.  
 
5.3. Limitations and Future Directions 
As an exploratory study to identify the effects of parabens on stromal cells, there are several 
limitations to this study. A single exposure to parabens was used in both fibroblasts and 
adipocytes, however, individuals are exposed to parabens multiple times per day for years. 
Therefore, longer term exposures could provide additional insights into parabens genomic 
effects such as altered epigenetics.  
 
Moreover, the contents of the CM were not analyzed and doing so via mass spectrometry 
would provide more information on which cytokines from paraben stimulation were 
translated into protein and secreted triggering breast cancer cell proliferation. Additionally, 
identifying the signaling pathway within the breast cancer epithelial cells that were 
enhanced upon treatment with CM could also solidify the findings. Therefore, conducting 
a more mechanistic signaling study with the MCF7 breast cancer cells would be a logical 
next step.  
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The human stromal cells utilized in this model had a difficult time differentiating after 
being infected with the lentivirus to make them immortal. With additional funding, a better 
technique would be to analyze primary stromal cells without infection. Primary stromal 
cells differentiated into adipocytes would be a better translatable model. Acquiring breast 
stromal cells from both premenopausal and postmenopausal women of both normal and 
obese BMI would enhance the study as well. Comparing the effects of BMI and menopause 
could show differences in the imposition of parabens and the effect of stromal 
inflammation of breast cancer cells. 
 
Since only in vitro studies were performed, future studies are needed to confirm the effects 
of parabens in breast stromal cells and breast cancer progression in vivo via xenograft of 
paraben treated stromal cells mixed with tumorigenic MCF7 cells in immunodeficient 
mice.  
 
To enhance this study, the utilization of breast epithelial cells representing all possible 
cancer types would provide significantly more information on the influence of inflamed 
stroma. For instance, imposing conditioned media upon non-cancerous breast epithelial 
cells (MCF10A), ER+/PR-/HER2- cells (MCF7), ER+/PR+/HER2- cells (T-47D), ER-
/PR-/HER2+ cells (SkBr3), and triple negative breast cancer cells (MDA-MB-231). The 
utilization of all these cancer cell types could expand our understanding of how paraben-
induced stromal inflammation on breast cancer development and progression and could 
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poster presentations: 
 Search for intelligence in honey bee queen behavior. North Carolina Honey Bee 
Research Consortium, 5th Annual Meeting, University of North Carolina at 
Greensboro, 17 April, 2010. (abstract) 
 Lack of rhythmicity in honey bee queen behavior. North Carolina Honey Bee Research 
Consortium, 5th Annual Meeting, University of North Carolina at Greensboro, 17 
April, 2010 (abstract) 
 Temporal behavior patterns of the honey bee (Apis mellifera). Poster presentation for 
the Appalachian Student Research Forum, 2009 
Emily has also been an author on publication as an undergraduate at ETSU 
 Absence of consistent diel rhythmicity in mated honey bee queen behavior. Journal of 
Insect Physiology. 2010 
After graduating from ETSU, Emily commissioned into the United States Navy as a Naval 
Officer with jobs in anti-submarine warfare. After serving four years, Emily returned to 
Knoxville with the family to tend to her mother diagnosed and succumbed to metastatic 
breast cancer. 
 
Emily began pursuing her Doctor of Philosophy degree in Cellular and Molecular Nutrition 
at the University of Tennessee at Knoxville (UTK). Whilst working toward her doctoral 
research on breast cancer, Emily has received many scholarships and worked as a graduate 
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teaching assistant (GTA) and graduate research assistant (GRA). In the time that Emily has 
been working towards her doctorate in Nutritional Science, she has lost her grandmother, 
her previous husband, and birthed two children. Throughout these trying times, Emily has 
continued to maintain a 3.9 GPA and completed all necessary experiments for her 
dissertation in Dr. Ling Zhao’s laboratory, which defended her dissertation on November 
1st, 2019. The experimental skills honed during this research include cell culture, genetic 
manipulation, cellular immortalization, cell functionality assays, rodent handling, surgical 
experience, bioluminescent imaging, etc. Computer programs mastered include Microsoft 
Word, Excel, PowerPoint, Sigma Plot, EndNote, SAS, SPSS, Canvas, MacMillan, and 
ImageJ. 
 
As a GRA, Emily managed the equipment and facilities of five labs. She learned and 
perfected communication skills with peers and external service companies. She 
coordinated repairs on a variety of experimental instruments critical for every study 
performed in the Cellular and Molecular Nutrition Department. Emily also functioned as 
the Bio-Safety contact for the Nutrition Department. Emily was also required to order and 
stock ethanol, liquid Nitrogen, Carbon Dioxide, and other tools necessary for daily 
laboratory operations. 
 
As a GTA for Nutrition 100, Emily helped teach undergraduates introductory nutrition and 
metabolism in a class setting. Emily was critical in the implementation of new programs 
utilized for this class including iClicker and MacMillan. 
While at UTK, Emily has authored the following poster presentations and publications: 
 Methylparaben and butylparaben alter multipotent mesenchymal stem cell fates toward 
adipocyte lineage. Toxicology and Applied Pharmacology. 2017 
 
Alongside academia, Emily has put countless hours into developing and implementing 
programs within Knoxville and the state of Tennessee in Veteran suicide prevention as the 
chairwoman of the Department of Veteran Affairs Knoxville Regional Mental Health 
Council, member of the Tennessee Veteran Suicide Prevention Task Force, and 
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chairwoman of Vet to Vet Tennessee Woman Veterans Committee. Emily organized and 
hosted two Women Veterans Summits in Knoxville in October 2018 and 2019. Emily is 
currently producing a theatrical play for suicide prevention geared toward the two highest-
risk populations, youth and Veterans, and she is developing a program for suicide 
prevention to be taught in Monroe County schools. Emily is currently a certified QPR-
Suicide Prevention Gatekeeper Instructor. Lastly, Emily is also collaborating with UTK 
Law School in hosting expungement clinics throughout Eastern Tennessee. 
 
